School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Omer Kucuk MD

  • Department of Hematology and Medical Oncology
    Professor
  • (404) 778-1900
Head shot of Omer Kucuk

Academic Appointment

  • Professor of Urology, Department of Urology, Emory University School of Medicine
  • Leader, Prostate Cancer Research Program, Winship Cancer Institute of Emory University
  • Professor of Hematology and Medical Oncology (Tenured), Department of Hematology and Medical Oncology, Emory University School of Medicine

Education

Degrees

  • MD from Hacettepe University Medical School

Research

Focus

  • My research focuses on the use of clinical trials in appropriate populations to demonstrate the efficacy and mechanisms of cancer preventive compounds in humans. Biomarkers of cancer risk and progression are used as intermediate endpoints and their modulation by chemopreventive agents are demonstrated in small clinical studies prior to the initiation of phase III clinical trials.

Publications

  • Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
    Cancer Volume: 129 Page(s): 3884 - 3893
    12/15/2023 Authors: Nazha B; Zhuang T; Wu S; Brown JT; Magee D; Carthon BC; Kucuk O; Nabhan C; Barata PC; Heath EI
  • Is vitamin A an antioxidant?
    Int J Vitam Nutr Res Volume: 93 Page(s): 481 - 482
    12/01/2023 Authors: Bohn T; Bhm V; Duliska-Litewka J; Landrier J-F; Bnti D; Kucuk O; Borel P; Canas JA; Rhl R
  • Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models.
    Br J Cancer Volume: 129 Page(s): 884 - 894
    09/01/2023 Authors: Li X; Chen Y; Bai L; Zhao R; Wu Y; Xie Z-R; Wu JM; Bowen NJ; Danaher A; Cook N
  • Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models.
    Transl Oncol Volume: 34 Page(s): 101707
    08/01/2023 Authors: Bai L; Li X; Yang Y; Zhao R; White EZ; Danaher A; Bowen NJ; Hinton CV; Cook N; Li D
  • Lycopene in Prevention of Infertility After Testicular Surgery Regarding Urology. 2022;164:267-272. doi:10.1016/j.urology.2021.11.044.
    Urology Volume: 175 Page(s): 236
    05/01/2023 Authors: Kucuk O
  • Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18 F-Fluciclovine PET/CT.
    Clin Nucl Med Volume: 48 Page(s): 361 - 363
    04/01/2023 Authors: Wu C; Marcus C; Baum Y; Kucuk O; Schuster DM
  • Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy.
    Clin Nucl Med Volume: 48 Page(s): e153 - e159
    04/01/2023 Authors: Lawal IO; Marcus C; Schuster DM; Goyal S; Adediran OA; Dhere VR; Joshi SS; Abiodun-Ojo OA; Master VA; Patel PR
  • Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial.
    J Nucl Med Volume: 64 Page(s): 586 - 591
    04/01/2023 Authors: Lawal IO; Jani AB; Adediran OA; Goyal S; Abiodun-Ojo OA; Dhere VR; Marcus CV; Joshi SS; Master VA; Patel PR
  • Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 28 Page(s): 239 - 245
    03/17/2023 Authors: Zhuang TZ; Ravindranathan D; Liu Y; Martini DJ; Brown JT; Nazha B; Russler G; Yantorni LB; Caulfield S; Carthon BC
  • Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy.
    Crit Rev Food Sci Nutr Volume: 63 Page(s): 2494 - 2508
    01/01/2023 Authors: Sahin TK; Bilir B; Kucuk O
  • Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [68Ga]Ga DOTATATE PET-CT.
    Cancers (Basel) Volume: 14
    12/08/2022 Authors: Bilen MA; Akintayo A; Liu Y; Abiodun-Ojo O; Kucuk O; Carthon BC; Schuster DM; Parent EE
  • Walk More, Eat Less, Don't Stress.
    Cancer Epidemiol Biomarkers Prev Volume: 31 Page(s): 1673 - 1674
    09/02/2022 Authors: Kucuk O
  • Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.
    J Immunother Precis Oncol Volume: 5 Page(s): 52 - 57
    08/01/2022 Authors: Martini DJ; Olsen TA; Goyal S; Liu Y; Evans ST; Hitron EE; Russler GA; Yantorni L; Caulfield S; Brown JT
  • Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood.
    J Immunother Cancer Volume: 10
    07/01/2022 Authors: Carlisle JW; Jansen CS; Cardenas MA; Sobierajska E; Reyes AM; Greenwald R; Del Balzo L; Prokhnevska N; Kucuk O; Carthon BC
  • High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells.
    Nat Commun Volume: 13 Page(s): 3385
    06/13/2022 Authors: Boya M; Ozkaya-Ahmadov T; Swain BE; Chu C-H; Asmare N; Civelekoglu O; Liu R; Lee D; Tobia S; Biliya S
  • Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials.
    Cancers (Basel) Volume: 14
    06/10/2022 Authors: Zhuang TZ; Case K; Olsen TA; Brown JT; Carthon BC; Kucuk O; Goldman J; Harris W; Bilen MA; Nazha B
  • Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
    Oncologist Volume: 27 Page(s): 462 - 468
    06/08/2022 Authors: Nazha B; Zhuang TZ; Dada HI; Drusbosky LM; Brown JT; Ravindranathan D; Carthon BC; Kucuk O; Goldman J; Master VA
  • Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer.
    Urol Oncol Volume: 40 Page(s): 271.e9 - 271.e18
    06/01/2022 Authors: Hadadi A; Smith KE; Wan L; Brown JR; Russler G; Yantorni L; Caulfield S; Lafollette J; Moore M; Kucuk O
  • Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.
    Clin Genitourin Cancer Volume: 20 Page(s): 53 - 59
    02/01/2022 Authors: Martini DJ; Evans ST; Liu Y; Shabto JM; Uner OE; Olsen TA; Brown JT; Russler GA; Yantorni L; Caulfield S
  • Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case report.
    Front Oncol Volume: 12 Page(s): 949400
    01/01/2022 Authors: Zhuang TZ; Harik L; Force S; Hadadi A; Bilen MA; Brown JT; Carthon BC; Goldman J; Kucuk O; Master VA
  • Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy.
    Front Endocrinol (Lausanne) Volume: 13 Page(s): 779915
    01/01/2022 Authors: Olsen TA; Zhuang TZ; Caulfield S; Martini DJ; Brown JT; Carthon BC; Kucuk O; Harris W; Bilen MA; Nazha B
  • Overcoming prostate cancer drug resistance with a novel organosilicon small molecule.
    Neoplasia Volume: 23 Page(s): 1261 - 1274
    12/01/2021 Authors: Zhao R; Ma X; Bai L; Li X; Mamouni K; Yang Y; Liu H; Danaher A; Cook N; Kucuk O
  • Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 26 Page(s): 1017 - 1025
    12/01/2021 Authors: Martini DJ; Shabto JM; Goyal S; Liu Y; Olsen TA; Evans ST; Magod BL; Ravindranathan D; Brown JT; Yantorni L
  • Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options.
    Oncologist Volume: 26 Page(s): 956 - 964
    11/01/2021 Authors: Smith KER; Brown JT; Wan L; Liu Y; Russler G; Yantorni L; Caulfield S; Lafollette J; Moore M; Kucuk O
  • Urolithiasis/Endourology.
    J Urol Volume: 206 Page(s): 1321 - 1324
    12/31/2021 Authors: Assimos DG
  • Negative enrichment of circulating tumor cells from unmanipulated whole blood with a 3D printed device.
    Sci Rep Volume: 11 Page(s): 20583
    10/18/2021 Authors: Chu C-H; Liu R; Ozkaya-Ahmadov T; Swain BE; Boya M; El-Rayes B; Akce M; Bilen MA; Kucuk O; Sarioglu AF
  • Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 26 Page(s): e1742 - e1750
    10/01/2021 Authors: Martini DJ; Goyal S; Liu Y; Evans ST; Olsen TA; Case K; Magod BL; Brown JT; Yantorni L; Russler GA
  • EDITORIAL COMMENT.
    Urology Volume: 156 Page(s): 209 - 210
    10/01/2021 Authors: Kucuk O
  • IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).
    J Immunother Cancer Volume: 9
    08/01/2021 Authors: Pachynski RK; Morishima C; Szmulewitz R; Harshman L; Appleman L; Monk P; Bitting RL; Kucuk O; Millard F; Seigne JD
  • Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications.
    Eur J Clin Microbiol Infect Dis Volume: 40 Page(s): 1587 - 1598
    08/01/2021 Authors: Kianmehr A; Faraoni I; Kucuk O; Mahrooz A
  • Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database.
    Clin Genitourin Cancer Volume: 19 Page(s): e193 - e199
    08/01/2021 Authors: Xu KM; Liu Y; Gillespie TW; Osunkoya AO; Carthon B; Bilen MA; Filson CP; Ogan K; Patel PR; Shelton JW
  • Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
    J Immunother Cancer Volume: 9
    07/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini D; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni L; Joshi SS
  • 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
    Lancet Volume: 397 Page(s): 1895 - 1904
    05/22/2021 Authors: Jani AB; Schreibmann E; Goyal S; Halkar R; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M
  • Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 26 Page(s): 397 - 405
    05/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni LB; Joshi SS
  • Effects of supplementing different chromium histidinate complexes on glucose and lipid metabolism and related protein expressions in rats fed a high-fat diet.
    J Trace Elem Med Biol Volume: 65 Page(s): 126723
    05/01/2021 Authors: Sahin K; Kucuk O; Orhan C; Erten F; Sahin N; Komorowski JR
  • Lycopene supplementation does not change productive performance but lowers egg yolk cholesterol and gene expression of some cholesterol-related proteins in laying hens.
    Br Poult Sci Volume: 62 Page(s): 227 - 234
    04/01/2021 Authors: Orhan C; Kucuk O; Sahin N; Tuzcu M; Sahin K
  • Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer.
    Nat Commun Volume: 12 Page(s): 1714
    03/17/2021 Authors: Zhang B; Li Y; Wu Q; Xie L; Barwick B; Fu C; Li X; Wu D; Xia S; Chen J
  • Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.
    Cancer Metastasis Rev Volume: 40 Page(s): 319 - 339
    03/01/2021 Authors: Mittal K; Kaur J; Jaczko M; Wei G; Toss MS; Rakha EA; Janssen EAM; Siland H; Kucuk O; Reid MD
  • Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
    Front Oncol Volume: 11 Page(s): 701345
    01/01/2021 Authors: Olsen TA; Martini DJ; Goyal S; Liu Y; Evans ST; Magod B; Brown JT; Yantorni L; Russler GA; Caulfield S
  • Exploratory study of 18F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancer.
    Am J Nucl Med Mol Imaging Volume: 11 Page(s): 218 - 229
    01/01/2021 Authors: Akintayo AA; Bilen MA; Abiodun-Ojo OA; Kucuk O; Carthon B; Chen Z; Jani AB; Parent EE; Schuster DM
  • Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
    Front Oncol Volume: 11 Page(s): 707050
    01/01/2021 Authors: Martini DJ; Olsen TA; Goyal S; Liu Y; Evans ST; Magod B; Brown JT; Yantorni L; Russler GA; Caulfield S
  • Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer.
    Theranostics Volume: 11 Page(s): 6873 - 6890
    01/01/2021 Authors: Li X; Gera L; Zhang S; Chen Y; Lou L; Wilson LM; Xie Z-R; Sautto G; Liu D; Danaher A
  • Awareness, Use and Outlook of Complementary and Alternative Medicine (CAM) Options in an Underserved, Uninsured Minority Cancer Patient Population.
    Integr Cancer Ther Volume: 20 Page(s): 15347354211051622
    01/01/2021 Authors: Bari S; Chineke I; Darwin A; Umar A; Jim H; Muzaffar J; Singh S; Kucuk O
  • Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database.
    Clin Transl Radiat Oncol Volume: 26 Page(s): 30 - 34
    01/01/2021 Authors: Janopaul-Naylor JR; Zhong J; Liu Y; Zhang C; Osunkoya AO; Joshi SS; Bilen MA; Carthon B; Kucuk O; Hartsell LM
  • Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib.
    Volume: 28 Page(s): 100393
    01/01/2021 Authors: Martini DJ; Kline MR; Liu Y; Shabto JM; Carthon BC; Russler GA; Yantorni L; Hitron EE; Caulfield S; Goldman JM
  • Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer.
    Volume: 108 Page(s): 1397
    12/01/2020 Authors: Jani A; Schreibmann E; Goyal S; Raghuveer H; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M
  • Kinless hubs are potential target genes in prostate cancer network.
    Genomics Volume: 112 Page(s): 5227 - 5239
    11/01/2020 Authors: Mangangcha IR; Malik MZ; Kucuk O; Ali S; Singh RKB
  • Novel small-molecule LG1836 inhibits the in vivo growth of castration-resistant prostate cancer.
    Prostate Volume: 80 Page(s): 993 - 1005
    09/01/2020 Authors: Chen Y; Li X; Mamouni K; Yang Y; Danaher A; White J; Liu H; Kucuk O; Gera L; Wu D
  • Effects of taurine supplementation on productive performance, nutrient digestibility and gene expression of nutrient transporters in quails reared under heat stress.
    J Therm Biol Volume: 92 Page(s): 102668
    08/01/2020 Authors: Orhan C; Kucuk O; Sahin N; Tuzcu M; Sahin K
  • A Dose-Dependent Effect of Carnipure Tartrate Supplementation on Endurance Capacity, Recovery, and Body Composition in an Exercise Rat Model.
    Nutrients Volume: 12
    05/23/2020 Authors: Sahin K; Orhan C; Kucuk O; Sahin N; Tuzcu M; Er B; Durkee S; Bellamine A
  • Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
    Cancer Med Volume: 9 Page(s): 2752 - 2760
    04/01/2020 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Brown J; Hitron EE; Russler GA; Caulfield S; Kissick H; Alemozaffar M
  • Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 25 Page(s): e484 - e491
    03/01/2020 Authors: Martini DJ; Liu Y; Shabto JM; Carthon BC; Hitron EE; Russler GA; Caulfield S; Kissick HT; Harris WB; Kucuk O
  • Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report.
    Front Oncol Volume: 10 Page(s): 622134
    01/01/2020 Authors: Bilen MA; Jiang JF; Jansen CS; Brown JT; Harik LR; Sekhar A; Kissick H; Maithel SK; Kucuk O; Carthon B
  • TGF- causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
    Theranostics Volume: 10 Page(s): 7656 - 7670
    01/01/2020 Authors: Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong J-T
  • Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer.
    Brachytherapy Volume: 19 Page(s): 557 - 566
    01/01/2020 Authors: Fischer-Valuck BW; Rao YJ; Brenneman RJ; Patel PR; Filson CP; Jani AB; Liu Y; Goyal S; Xu K; Weiss A
  • Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist
    12/05/2019 Authors: Martini DJ; Liu Y; Shabto JM; Carthon BC; Hitron EE; Russler GA; Caulfield S; Kissick HT; Harris WB; Kucuk O
  • Identification of key regulators in prostate cancer from gene expression datasets of patients.
    Sci Rep Volume: 9 Page(s): 16420
    11/11/2019 Authors: Mangangcha IR; Malik MZ; Kk ; Ali S; Singh RKB
  • Habitat suitability model with maximum entropy approach for European roe deer (Capreolus capreolus) in the Black Sea Region.
    Environ Monit Assess Volume: 191 Page(s): 669
    10/24/2019 Authors: Evcin O; Kucuk O; Akturk E
  • Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients.
    Clin Otolaryngol Volume: 44 Page(s): 639 - 643
    07/01/2019 Authors: Sukari A; Nagasaka M; Diab M; Al Sibai K; Atassi B; Elayoubi JA; Kim S; Kk
  • Novel risk stratification criteria of metastatic renal cell carcinoma (mRCC) patients (pts) treated with immune checkpoint inhibitors (ICI).
    Volume: 37
    05/20/2019 Authors: Martini DJ; Liu Y; Shabto JM; Carthon BC; Russler G; Hitron E; Caulfield S; Kissick H; Harris W; Kucuk O
  • [F-18]-fluciclovine positivity rate is not affected by androgen deprivation therapy (ADT) in recurrent prostate cancer post-prostatectomy.
    Volume: 60
    05/01/2019 Authors: Abiodun-Ojo O; Jani A; Akintayo A; Alemozaffar M; Akin-Akintayo O; Odewole O; Tade F; Nieh P; Master V; Patel P
  • Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models.
    Cancer Lett Volume: 446 Page(s): 62 - 72
    04/01/2019 Authors: Chen Y; Gera L; Zhang S; Li X; Yang Y; Mamouni K; Wu AY; Liu H; Kucuk O; Wu D
  • Genistein Prevents Development of Spontaneous Ovarian Cancer and Inhibits Tumor Growth in Hen Model.
    Cancer Prev Res (Phila) Volume: 12 Page(s): 135 - 146
    03/01/2019 Authors: Sahin K; Yenice E; Bilir B; Orhan C; Tuzcu M; Sahin N; Ozercan IH; Kabil N; Ozpolat B; Kucuk O
  • Analysis of toxicity and clinical outcomes (CO) in full versus reduced dose cabozantinib (cabo) in metastatic renal cell carcinoma (mRCC) patients (pts).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Association of inflammation and clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Sites of metastases (mets) and their association with clinical outcomes (CO) in urothelial cancer patients (pts) treated with immunotherapy (IO).
    Volume: 37
    03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
  • Association between immune-related adverse events (irAEs) and clinical outcomes (CO) in advanced urothelial cancer patients (pts) treated with immunotherapy (IO).
    Volume: 37
    03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
  • Inflammatory markers at baseline (C1) and cycle 3 (C3) and their association with clinical outcomes in urothelial cancer patients (pts) treated with immunotherapy (IO).
    Volume: 37
    03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
  • Body mass index (BMI) and toxicities and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Sites of metastasis (mets) and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Tomato Powder Modulates NF-B, mTOR, and Nrf2 Pathways during Aging in Healthy Rats.
    J Aging Res Volume: 2019 Page(s): 1643243
    01/01/2019 Authors: Sahin K; Orhan C; Tuzcu M; Tastan H; Bilir B; Sahin N; Oner DA; Kucuk O
  • Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell Carcinoma.
    Nutr Cancer Volume: 71 Page(s): 772 - 780
    01/01/2019 Authors: Rozek LS; Virani S; Bellile EL; Taylor JMG; Sartor MA; Zarins KR; Virani A; Cote C; Worden FP; Mark MEP
  • Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
    J Clin Oncol Volume: 37 Page(s): 44 - 51
    01/01/2019 Authors: Coen JJ; Zhang P; Saylor PJ; Lee CT; Wu C-L; Parker W; Lautenschlaeger T; Zietman AL; Efstathiou JA; Jani AB
  • Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy.
    Integr Cancer Ther Volume: 18 Page(s): 1534735419835310
    01/01/2019 Authors: Sahin I; Bilir B; Ali S; Sahin K; Kucuk O
  • Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.
    Volume: 42 Page(s): 36 - 41
    01/01/2019 Authors: Zhong J; Switchenko J; Jegadeesh NK; Cassidy RJ; Gillespie TW; Master V; Nieh P; Alemozaffar M; Kucuk O; Carthon B
  • Phytochemicals in Integrative Oncology
    Volume: 225 Page(s): 7 - 7
    12/01/2018 Authors: Kucuk O
  • Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial.
    JMIR Res Protoc Volume: 7 Page(s): e11257
    11/15/2018 Authors: Winters-Stone KM; Kenfield SA; Van Blarigan EL; Moe EL; Ramsdill JW; Daniel K; Macaire G; Paich K; Kessler ER; Kucuk O
  • The addition of chemotherapy in the definitive management of high risk prostate cancer.
    Urol Oncol Volume: 36 Page(s): 475 - 487
    11/01/2018 Authors: Ferris MJ; Liu Y; Ao J; Zhong J; Abugideiri M; Gillespie TW; Carthon BC; Bilen MA; Kucuk O; Jani AB
  • FOOD HABITS AND CANCER PREVENTION
    Volume: 55-56 Page(s): S11 - S13
    10/01/2018 Authors: Kucuk O
  • Serial Measurements of C-Reactive Protein: Albumin Ratio Can Stratify Risk and Survival in Patients with Clear Cell Renal Cell Carcinoma
    Volume: 227 Page(s): E245 - E245
    10/01/2018 Authors: Laganosky DD; Khan AI; Patil D; Lay AH; Pattaras JG; Bilen MA; Kucuk O; Ogan K; Master V
  • High Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in Localized and Metastatic Clear Cell Renal Cell Carcinoma
    Volume: 227 Page(s): E243 - E243
    10/01/2018 Authors: Khan AI; Melnick KR; Patil D; Kim F; Laganosky DD; Bilen MA; Kucuk O; Filson CP; Ogan K; Master V
  • New Preoperative Inflammatory Score Is an Independent and Significant Predictor of Overall Survival in Localized Clear Cell Renal Cell Carcinoma
    Volume: 227 Page(s): E244 - E244
    10/01/2018 Authors: Melnick KR; Khan AI; Patil D; Kim F; Patel AP; Bilen MA; Kucuk O; Filson CP; Ogan K; Master V
  • Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer.
    Mol Cancer Ther Volume: 17 Page(s): 1859 - 1870
    09/01/2018 Authors: Yang Y; Mamouni K; Li X; Chen Y; Kavuri S; Du Y; Fu H; Kucuk O; Wu D
  • A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models.
    Neoplasia Volume: 20 Page(s): 789 - 799
    08/01/2018 Authors: Mamouni K; Zhang S; Li X; Chen Y; Yang Y; Kim J; Bartlett MG; Coleman IM; Nelson PS; Kucuk O
  • Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab.
    Clin Genitourin Cancer Volume: 16 Page(s): e563 - e575
    06/01/2018 Authors: Bilen MA; Dutcher GMA; Liu Y; Ravindranathan D; Kissick HT; Carthon BC; Kucuk O; Harris WB; Master VA
  • Retraction notice to: Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents.
    Cancer Lett Volume: 423 Page(s): 154
    06/01/2018 Authors: Ali S; Varghese L; Pereira L; Tulunay-Ugur OE; Kucuk O; Carey TE; Wolf GT; Sarkar FH
  • Design, synthesis, and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates.
    Bioorg Med Chem Volume: 26 Page(s): 1481 - 1487
    05/01/2018 Authors: George A; Raji I; Cinar B; Kucuk O; Oyelere AK
  • Compatible above-ground biomass equations and carbon stock estimation for small diameter Turkish pine (Pinus brutia Ten.).
    Environ Monit Assess Volume: 190 Page(s): 285
    04/15/2018 Authors: Sakici OE; Kucuk O; Ashraf MI
  • Randomized phase 2 trial of radiation with either gemcitabine or 5FU/cisplatin in bladder cancer
    Volume: 127 Page(s): S24 - S25
    04/01/2018 Authors: Shipley WU; Zhang P; Saylor P; Lee C; Wu CL; Parker W; Lautenschlaeger T; Zietman A; Efstathiou J; Jani A
  • Lycopene Protects Against Spontaneous Ovarian Cancer Formation in Laying Hens.
    J Cancer Prev Volume: 23 Page(s): 25 - 36
    03/01/2018 Authors: Sahin K; Yenice E; Tuzcu M; Orhan C; Mizrak C; Ozercan IH; Sahin N; Yilmaz B; Bilir B; Ozpolat B
  • Single center validation of neutrophil-to-lymphocyte ratio in localized and metastatic clear cell renal cell carcinoma.
    Volume: 36
    02/20/2018 Authors: Melnick KR; Patil DH; Khan AI; Kim FY; Torlak M; Bilen MA; Kucuk O; Carthon BC; Filson CP; Ogan K
  • Evaluation of preoperative C-reactive protein: Albumin ratio in patients with clear cell renal cell carcinoma.
    Volume: 36
    02/20/2018 Authors: Patil DH; Williams S; Torlak M; Alemozaffar M; Lay A; Pattaras J; Kucuk O; Carthon BC; Bilen MA; Ogan K
  • Validation of a novel preoperative inflammatory score in localized, clear cell RCC.
    Volume: 36
    02/20/2018 Authors: Melnick KR; Patil DH; Khan AI; Kim FY; Bilen MA; Carthon BC; Kucuk O; Filson CP; Ogan K; Kissick HT
  • Chemopreventive and Antitumor Efficacy of Curcumin in a Spontaneously Developing Hen Ovarian Cancer Model.
    Cancer Prev Res (Phila) Volume: 11 Page(s): 59 - 67
    01/01/2018 Authors: Sahin K; Orhan C; Tuzcu M; Sahin N; Tastan H; zercan H; Gler O; Kahraman N; Kucuk O; Ozpolat B
  • The impact of psychological distress during pregnancy on the developing fetus: biological mechanisms and the potential benefits of mindfulness interventions.
    J Perinat Med Volume: 45 Page(s): 999 - 1011
    12/20/2017 Authors: Isgut M; Smith AK; Reimann ES; Kucuk O; Ryan J
  • Selective Bladder Preservation with Twice-Daily Radiation Plus 5-Flourouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Patients with Muscle Invasive Bladder Cancer-Primary Results of NRG/RTOG 0712: A Randomized Phase 2 Multicenter Trial
    Volume: 99 Page(s): 1319 - 1319
    12/01/2017 Authors: Coen JJ; Zhang P; Saylor PJ; Lee CT; Wu CL; Parker W; Lautenschlaeger T; Zietman AL; Efstathiou JA; Jani A
  • A Comprehensive Definition for Integrative Oncology.
    J Natl Cancer Inst Monogr Volume: 2017
    11/01/2017 Authors: Witt CM; Balneaves LG; Cardoso MJ; Cohen L; Greenlee H; Johnstone P; Kck ; Mailman J; Mao JJ
  • Mifepristone Has Limited Activity to Enhance the In Vivo Efficacy of Docetaxel and Enzalutamide Against Bone Metastatic and Castration-Resistant Prostate Cancer.
    Anticancer Res Volume: 37 Page(s): 6235 - 6243
    11/01/2017 Authors: Yang Y; Li X; Mamouni K; Kucuk O; Wu D
  • A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma.
    Asian J Urol Volume: 4 Page(s): 230 - 238
    10/01/2017 Authors: Sekar RR; Patil D; Baum Y; Pearl J; Bausum A; Bilen MA; Kucuk O; Harris WB; Carthon BC; Alemozaffar M
  • Visibility analysis of fire lookout towers in the Boyabat State Forest Enterprise in Turkey.
    Environ Monit Assess Volume: 189 Page(s): 329
    07/01/2017 Authors: Kucuk O; Topaloglu O; Altunel AO; Cetin M
  • Effects of genistein supplementation on genomewide DNA methylation and gene expression in patients with localized prostate cancer.
    Int J Oncol Volume: 51 Page(s): 223 - 234
    07/01/2017 Authors: Bilir B; Sharma NV; Lee J; Hammarstrom B; Svindland A; Kucuk O; Moreno CS
  • Mechanism of anticancer activity of BPS-001 (lyophilized leech saliva extract)
    Volume: 77
    07/01/2017 Authors: Ammar A; Guns E; Kucuk O; Abdualkader A; Alaama M; Uddin ABMH; Ghawi A; Hassona M
  • Time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma.
    Tumour Biol Volume: 39 Page(s): 1010428317705514
    06/01/2017 Authors: Harris WB; Zhang C; Liu Y; Robertson DK; Akbashev MY; Lingerfelt BM; Kucuk O; Carthon BC; Gillespie TW; Osunkoya AO
  • Soy foods, isoflavones, and breast cancer.
    Cancer Volume: 123 Page(s): 1901 - 1903
    06/01/2017 Authors: Kucuk O
  • Single institution experience on papillary renal cell carcinoma PD-1/13D-L1 expression, pathological analysis, and outcomes after nephrectomy.
    Volume: 35
    05/20/2017 Authors: Carthon BC; Tabba M; Harris W; Kucuk O; Master VA; Ogan K; Osunkoya A; Ellis C
  • Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology.
    Urol Oncol Volume: 35 Page(s): 250 - 256
    05/01/2017 Authors: Gerhard RS; Patil D; Liu Y; Ogan K; Alemozaffar M; Jani AB; Kucuk ON; Master VA; Gillespie TW; Filson CP
  • Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial.
    J Nucl Med Volume: 58 Page(s): 412 - 418
    03/01/2017 Authors: Jani AB; Schreibmann E; Rossi PJ; Shelton J; Godette K; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R
  • Gastroenteropancreatic neuroendocrine tumors: recommendations of Turkish multidisciplinary neuroendocrine tumor study group on diagnosis, treatment and follow-up.
    Arch Med Sci Volume: 13 Page(s): 271 - 282
    03/01/2017 Authors: Yalcin S; Bayram F; Erdamar S; Kucuk O; Oruc N; Coker A
  • Retrospective review of cytotoxic chemotherapy and anti-angiogenic combinations in renal cell carcinoma: A single institution experience.
    Volume: 35
    02/20/2017 Authors: Carthon BC; Tabba M; Ellis C; Harris W; Bilen MA; Canter D
  • Biomarker study of early death in patients with intermediate and favorable risk metastatic renal cell carcinoma.
    Volume: 35
    02/20/2017 Authors: Harris W; Zhang C; Liu Y; Kucuk O; Carthon BC; Master VA
  • The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer.
    Volume: 123 Page(s): 512 - 520
    02/01/2017 Authors: Jegadeesh N; Liu Y; Zhang C; Zhong J; Cassidy RJ; Gillespie T; Kucuk O; Rossi P; Master VA; Alemozaffar M
  • Prognostic Biomarkers of Systemic Inflammation in Patients with Metastatic Renal Cell Carcinoma
    Volume: 97 Page(s): 229A - 229A
    02/01/2017 Authors: Harris WB; Kucuk O; Carthon BC; Gillespie TW; Master VA; Osunkoya AO
  • Prognostic Biomarkers of Systemic Inflammation in Patients with Metastatic Renal Cell Carcinoma
    Volume: 30 Page(s): 229A - 229A
    02/01/2017 Authors: Harris WB; Kucuk O; Carthon BC; Gillespie TW; Master VA; Osunkoya AO
  • Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.
    Bone Marrow Transplant Volume: 52 Page(s): 132 - 134
    01/01/2017 Authors: DeFilipp Z; Rosand CB; Goldstein DA; Master VA; Carthon BC; Harris WB; Kucuk O; Al-Kadhimi Z; Cohen JB; Flowers CR
  • Lycopene in the Prevention of Radiation-Induced Esophagitis.
    Nutr Cancer Volume: 69 Page(s): 319 - 329
    01/01/2017 Authors: Coskun H; Andic F; Dagloglu YK; Doran F; Sahin K; Tunal C; Kucuk O
  • Comparison of Outcomes in Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Chemoradiation.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): S93 - S94
    10/01/2016 Authors: Zhong J; Switchenko J; Jegadeesh N; Gillespie TW; Master VA; Nieh P; Alemozaffar M; Kucuk O; Carthon B; Filson CP
  • Genistein-AR antagonist conjugate potently induce growth arrest in both androgen dependent and independent prostate cancer cell lines
    Volume: 76
    07/01/2016 Authors: Raji IO; George A; Kucuk O; Oyelere AK
  • Soy isoflavones modulate global methylation in head and neck squamous cell carcinoma (HNSCC)
    Volume: 76
    07/01/2016 Authors: Rozek L; Virani S; Bellile E; Taylor J; Sartor M; Virani A; Rentschler K; Cote C; Worden F; Peterson L
  • Comparison of survival, safety, and efficacy after transarterial chemoembolization and radioembolization of Barcelona Clinic Liver Cancer stage B-C hepatocellular cancer patients.
    Nucl Med Commun Volume: 37 Page(s): 646 - 649
    06/01/2016 Authors: Soydal C; Arslan MF; Kucuk ON; Idilman R; Bilgic S
  • Ginger augmented chemotherapy: A novel multitarget nontoxic approach for cancer management.
    Mol Nutr Food Res Volume: 60 Page(s): 1364 - 1373
    06/01/2016 Authors: Saxena R; Rida PCG; Kucuk O; Aneja R
  • Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644: an aminobisphosphonate derivative.
    Oncotarget Volume: 7 Page(s): 27489 - 27498
    05/10/2016 Authors: Zhang S; Gera L; Mamouni K; Li X; Chen Z; Kucuk O; Wu D
  • Lycopene activates antioxidant enzymes and nuclear transcription factor systems in heat-stressed broilers.
    Poult Sci Volume: 95 Page(s): 1088 - 1095
    05/01/2016 Authors: Sahin K; Orhan C; Tuzcu M; Sahin N; Hayirli A; Bilgili S; Kucuk O
  • DELAYED TREATMENT OF HIGH-RISK PROSTATE CANCER PATIENTS: IMPACT OF SOCIOECONOMIC BARRIERS AND USE OF ADVANCED TECHNOLOGIES
    Volume: 195 Page(s): E499 - E499
    04/01/2016 Authors: Gerhard RS; Patil D; Liu Y; Ogan K; Alemozaffar M; Jani A; Kucuk O; Master V; Gillespie T; Filson C
  • Can Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Be Used As a Useful Method to Evaluate the Treatment Response to Neoadjuvant Therapy Combined With Sorafenib and Anti-VEGF in Children Diagnosed With Metastatical Bone Sarcoma?
    Iran J Pediatr Volume: 26 Page(s): e4008
    04/01/2016 Authors: Tacyildiz N; Tanyildiz HG; Dincaslan HU; Yavuz G; Unal E; Ozkan E; Soydal C; Kucuk O; Yildiz Y
  • High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Previously Treated Germ Cell Tumors: A Single-Center Experience
    Volume: 22 Page(s): S421 - S422
    03/01/2016 Authors: DeFilipp Z; Rosand CB; Goldstein DA; Master VA; Carthon BC; Harris WB; Kucuk O; Waller EK
  • Abstract A46: Effects of genistein supplementation on genome-wide DNA methylation and gene expression in patients with localized prostate cancer
    Volume: 76
    01/15/2016 Authors: Bilir B; Lee JE; Sharma NV; Lazarevic B; Svindland A; Kucuk O; Moreno CS
  • Dynamic correlation of serum C-reactive protein (CRP) levels with serum prostate-specific antigen (PSA) levels in patients with prostate cancer (PCa) on androgen deprivation therapy (ADT).
    Volume: 34
    01/10/2016 Authors: Kucuk O; Balci B; Liu Y; Zhang C; Yilmaz B; Atag E; Karaoglu A; Jani AB; Harris W; Carthon BC
  • Nephrectomy status, race, and overall survival in patients with metastatic renal cell carcinoma.
    Volume: 34
    01/10/2016 Authors: Robertson DK; Zhang C; Liu Y; Gillespie TW; Kucuk O; Carthon BC; Master VA; Issa M; Petros J; Harris WB
  • A novel preoperative inflammatory marker prognostic score in patients with clear cell and non-clear cell renal cell carcinoma.
    Volume: 34
    01/10/2016 Authors: Sekar RR; Patil D; Pearl J; Baum Y; Kucuk O; Harris WB; Carthon B; Alemozaffar M; Filson CP; Ogan K
  • BPS-001, a complex biologic agent extracted from the medicinal leech (Huridinaria manillensis) for treatment of metastatic castration-resistant prostate cancer.
    Volume: 34
    01/10/2016 Authors: Stratton MS; Ammar A; Wang Y; Hessein M; Guns E; Kucuk O; Merzouk A; Kwok D
  • The role of adjuvant radiotherapy in pathologically node positive prostate cancer
    Volume: 34
    01/10/2016 Authors: Jegadeesh N; Liu Y; Zhang C; Zhong J; Gillespie TW; Kucuk O; Rossi PJ; Master VA; Alemozaffar M; Jani AB
  • Laying performance, digestibility and plasma hormones in laying hens exposed to chronic heat stress as affected by betaine, vitamin C, and/or vitamin E supplementation.
    Springerplus Volume: 5 Page(s): 1619
    01/01/2016 Authors: Attia YA; Abd El-Hamid AE-HE; Abedalla AA; Berika MA; Al-Harthi MA; Kucuk O; Sahin K; Abou-Shehema BM
  • Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.
    Semin Cancer Biol Volume: 35 Suppl Page(s): S55 - S77
    12/01/2015 Authors: Amin ARMR; Karpowicz PA; Carey TE; Arbiser J; Nahta R; Chen ZG; Dong J-T; Kucuk O; Khan GN; Huang GS
  • How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity.
    Cancer Metastasis Rev Volume: 34 Page(s): 703 - 713
    12/01/2015 Authors: Rida PCG; Cantuaria G; Reid MD; Kucuk O; Aneja R
  • Designing a broad-spectrum integrative approach for cancer prevention and treatment.
    Semin Cancer Biol Volume: 35 Suppl Page(s): S276 - S304
    12/01/2015 Authors: Block KI; Gyllenhaal C; Lowe L; Amedei A; Amin ARMR; Amin A; Aquilano K; Arbiser J; Arreola A; Arzumanyan A
  • Impact of Anti-3-[18F]FACBC Positron Emission Tomography on Target Volume Definition After Prostatectomy: Initial Findings From a Randomized Trial
    Volume: 93 Page(s): S135 - S135
    11/01/2015 Authors: Jani A; Schreibmann E; Rossi PJ; Shelton JW; Godette KD; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R
  • C-reactive protein in urologic cancers.
    Mol Aspects Med Volume: 45 Page(s): 28 - 36
    11/01/2015 Authors: Huang J; Baum Y; Alemozaffar M; Ogan K; Harris W; Kucuk O; Master VA
  • Cancer biomarkers.
    Mol Aspects Med Volume: 45 Page(s): 1 - 2
    11/01/2015 Authors: Kucuk O
  • Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse.
    Cancer Lett Volume: 367 Page(s): 89 - 92
    10/28/2015 Authors: Ogden A; Rida PCG; Knudsen BS; Kucuk O; Aneja R
  • Assessment of the antitumor activity of leech (huridinaria manillensis) saliva extract in prostate cancer
    Volume: 75
    08/01/2015 Authors: Ammar AE; Hassona MH; Meckling GR; Chan LG; Chin MY; Abdualkader A; Alaama M; Merzouk A; Helaluddin A; Ghawi A
  • Kinetic risk assessment with biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma
    Volume: 75
    08/01/2015 Authors: Harris WB; Kucuk O; Carthon B; Liu Y; Pattaras J; Ogan K; Master V
  • Mechanisms of genistein in cancer prevention and treatment
    Volume: 26 Page(s): E4 - E4
    08/01/2015 Authors: Kucuk O
  • Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases.
    Can J Urol Volume: 22 Page(s): 7783 - 7787
    06/01/2015 Authors: Fatima N; Canter DJ; Carthon BC; Kucuk O; Master VA; Nieh PT; Ogan K; Osunkoya AO
  • Carotenoids and non-alcoholic fatty liver disease.
    Hepatobiliary Surg Nutr Volume: 4 Page(s): 161 - 171
    06/01/2015 Authors: Yilmaz B; Sahin K; Bilen H; Bahcecioglu IH; Bilir B; Ashraf S; Halazun KJ; Kucuk O
  • Assessment of the antitumor activity of leech (huridinaria manillensis) saliva extract in prostate cancer.
    Volume: 33
    05/20/2015 Authors: Hessein M; Ammar A; Chin M; Abdualkader A; Alaama M; Merzouk A; Helaluddin AB; Ghawi A; Kucuk O; Guns E
  • Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model.
    Volume: 572 Page(s): 36 - 39
    04/15/2015 Authors: Sahin K; Cross B; Sahin N; Ciccone K; Suleiman S; Osunkoya AO; Master V; Harris W; Carthon B; Mohammad R
  • Die-hard survivors: heterogeneity in apoptotic thresholds may underlie chemoresistance.
    Expert Rev Anticancer Ther Volume: 15 Page(s): 277 - 281
    03/01/2015 Authors: Ogden A; Rida PCG; Reid MD; Kucuk O; Aneja R
  • In vivo assessment of the therapeutic effects of lyophilized leech saliva extract from (Huridinaria manillensis) on LNCaP tumor xenograft model in nude mice.
    Volume: 33
    03/01/2015 Authors: Ammar A; Hessein M; Guns E; Chin M; Helaluddin AB; Abdualkader A; Alaama M; Merzouk A; Ghawi A; Kucuk O
  • Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck.
    Avicenna J Med Volume: 5 Page(s): 36 - 41
    01/01/2015 Authors: Sukari A; Al-Hajeili M; Salem M; Heilbrun L; Smith D; Yoo G; Jacobs JR; Lin H-S; Kucuk O
  • Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329.
    Head Neck Volume: 36 Page(s): 1712 - 1717
    12/01/2014 Authors: Malhotra B; Moon J; Kucuk O; Clark JI; Urba SG; Wolf GT; Worden FP
  • Prospective international cohort study demonstrates inability of interim PET to predict treatment failure in diffuse large B-cell lymphoma.
    J Nucl Med Volume: 55 Page(s): 1936 - 1944
    12/01/2014 Authors: Carr R; Fanti S; Paez D; Cerci J; Gyrke T; Redondo F; Morris TP; Meneghetti C; Auewarakul C; Nair R
  • Eugenol-rich Fraction of Syzygium aromaticum (Clove) Reverses Biochemical and Histopathological Changes in Liver Cirrhosis and Inhibits Hepatic Cell Proliferation.
    J Cancer Prev Volume: 19 Page(s): 288 - 300
    12/01/2014 Authors: Ali S; Prasad R; Mahmood A; Routray I; Shinkafi TS; Sahin K; Kucuk O
  • Inflammation-free survival as a surrogate endpoint for overall survival in patients with metastatic renal cell carcinoma
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Volume: 23
    11/01/2014 Authors: Harris WB; Nickleach DC; Liu Y; Kucuk O; Master VA
  • Genistein protects hematopoietic stem cells against G-CSF-induced DNA damage.
    Cancer Prev Res (Phila) Volume: 7 Page(s): 534 - 544
    05/01/2014 Authors: Souza LR; Silva E; Calloway E; Kucuk O; Rossi M; McLemore ML
  • Enhancement of Cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallate.
    Front Nutr Volume: 1 Page(s): 28
    01/01/2014 Authors: Kilic U; Sahin K; Tuzcu M; Basak N; Orhan C; Elibol-Can B; Kilic E; Sahin F; Kucuk O
  • External validation of the modified Glasgow prognostic score for renal cancer.
    Indian J Urol Volume: 30 Page(s): 33 - 37
    01/01/2014 Authors: Tai CG; Johnson TV; Abbasi A; Herrell L; Harris WB; Kucuk O; Canter DJ; Ogan K; Pattaras JG; Nieh PT
  • Pomegranate extract inhibits the bone metastatic growth of human prostate cancer cells and enhances the in vivo efficacy of docetaxel chemotherapy.
    Prostate
    12/23/2013 Authors: Wang Y; Zhang S; Iqbal S; Chen Z; Wang X; Wang YA; Liu D; Bai K; Ritenour C; Kucuk O
  • Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.
    J Transl Med Volume: 11 Page(s): 280
    11/04/2013 Authors: Bilir B; Kucuk O; Moreno CS
  • Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells.
    Prostate Volume: 73 Page(s): 1681 - 1689
    11/01/2013 Authors: Zhang S; Wang Y; Chen Z; Kim S; Iqbal S; Chi A; Ritenour C; Wang YA; Kucuk O; Wu D
  • Clinical utility of biomarkers of systemic inflammation for patients with metastatic renal cell carcinoma.
    Volume: 31
    05/20/2013 Authors: Harris W; Akbashev MY; Kucuk O; Liu Y; Hsiao W; Osunkoya AO; Baumgarten DO; Master VA
  • Genistein protects hematopoietic stem cells against G-CSF induced DNA damage.
    Volume: 73
    04/15/2013 Authors: Souza L; Silva E; Rossi M; Kucuk O; Mclemore ML
  • Ethnic disparities in prognosis associated with persistence of the systemic inflammatory response in metastatic renal cell carcinoma.
    Volume: 73
    04/15/2013 Authors: Harris WB; Gao J; Nickleach DC; Liu Y; Kucuk O; Master V
  • NOMOGRAMS INCORPORATING SERUM C-REACTIVE PROTEIN (CRP) LEVELS EFFECTIVELY PREDICT MORTALITY AFTER NEPHRECTOMY.
    Volume: 189 Page(s): E306 - E307
    04/01/2013 Authors: Hsiao W; Herrel L; Yu C; Kattan M; Ogan K; Canter D; Pattaras J; Nieh P; Harris W; Carthon B
  • Proceedings of the Indo-U.S. bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survival.
    Cancer Med Volume: 2 Page(s): 108 - 115
    02/01/2013 Authors: Kumar NB; Dhurandhar M; Aggarwal B; Anant S; Daniel K; Deng G; Djeu J; Dou J; Hawk E; Jayaram B
  • Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition.
    J Biol Chem Volume: 288 Page(s): 1469 - 1479
    01/18/2013 Authors: Zhang S; Wang X; Iqbal S; Wang Y; Osunkoya AO; Chen Z; Chen Z; Shin DM; Yuan H; Wang YA
  • The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy.
    Br J Nutr Volume: 108 Page(s): 2138 - 2147
    12/28/2012 Authors: Lazarevic B; Hammarstrm C; Yang J; Ramberg H; Diep LM; Karlsen SJ; Kucuk O; Saatcioglu F; Taskn KA; Svindland A
  • Lycopene counteracts the hepatic response to 7,12-dimethylbenz[a]anthracene by altering the expression of Bax, Bcl-2, caspases, and oxidative stress biomarkers.
    Pharm Biol Volume: 50 Page(s): 1513 - 1518
    12/01/2012 Authors: Agca CA; Tuzcu M; Gencoglu H; Akdemir F; Ali S; Sahin K; Kucuk O
  • Genistein Protects Hematopoietic Stem Cells Against G-CSF Induced DNA Damage
    Volume: 120
    11/16/2012 Authors: Souza L; Silva E; Calloway E; Rossi M; Kucuk O; McLemore ML
  • Genistein Protects Hematopoietic Stem Cells Against G-CSF Induced DNA Damage
    Volume: 120
    11/16/2012 Authors: Souza L; Silva E; Calloway E; Rossi M; Kucuk O; McLemore ML
  • Fiber digestion with fat feeding through the rumen microbial ecosystem
    Volume: 161 Page(s): 5 - 5
    11/01/2012 Authors: Kucuk O
  • PHASE II STUDY OF BIWEEKLY DOSE-INTENSE PACLITAXEL PLUS GEMCITABINE (GEM/TAX) IN PATIENTS WITH RECURRENT LOCOREGIONAL OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Volume: 23 Page(s): 342 - 342
    09/01/2012 Authors: Sukari A; Salem M; Al-Hajeili M; Jacobs J; Taylo S; Yoo G; Lin H; Heilbrun L; Alousi A; Kucuk O
  • Tomato powder impedes the development of azoxymethane-induced colorectal cancer in rats through suppression of COX-2 expression via NF-B and regulating Nrf2/HO-1 pathway.
    Mol Nutr Food Res Volume: 56 Page(s): 1477 - 1481
    09/01/2012 Authors: Tuzcu M; Aslan A; Tuzcu Z; Yabas M; Bahcecioglu IH; Ozercan IH; Kucuk O; Sahin K
  • Vitamin D levels in patients with childhood cancer.
    Volume: 30
    05/20/2012 Authors: Tacyildiz N; Tanyildiz GO; Tekin D; Ates C; Dincaslan H; Yavuz G; Unal E; Kose K; Ozyoruk D; Suskan E
  • Methotrexate and cetuximab for metastatic advanced head and neck squamous cell carcinoma: A retrospective study
    Volume: 30
    05/20/2012 Authors: Atassi B; Alsibai K; Yoo GH; Lin H-S; Dyson G; Kim H; Jacobs JR; Kucuk O; Sukari A
  • Phase II study of biweekly dose-intense docetaxel plus gemcitabine (GEM/DOC) in patients with recurrent locoregional or metastatic head and neck squamous cell carcinoma.
    Volume: 30
    05/20/2012 Authors: Sukari A; Kafri Z; Heilbrun LK; Yoo GH; Mulrenan HA; Smith D; Kim H; Jacobs JR; Kucuk O; Salem ME
  • Efficacy and tolerability of biweekly gemcitabine plus cisplatin (GEMCIS) or gemcitabine plus paclitaxel (GEMPAC) as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
    Volume: 30
    05/20/2012 Authors: Karaoglu A; Nieh P; Canter D; Master VA; Carthon B; Harris W; Shelton J; Rossi PJ; Jani AB; Khan MK
  • Phase I results from a phase I/II study of orteronel, an oral, investigational, nonsteroidal 17,20-lyase inhibitor, with docetaxel and prednisone (DP) in metastatic castration-resistant prostate cancer (mCRPC).
    Volume: 30
    05/20/2012 Authors: Petrylak DP; Gandhi JG; Clark WR; Heath EI; Lin J; Oh WK; Agus DB; Kucuk O; Moran S; Wang J
  • Prognostic value of post-induction PET/CT in untreated multiple myeloma (MM) patients undergoing autologous stem cell transplant (ASCT)
    Volume: 30
    05/20/2012 Authors: Kostakoglu L; Dingli D; Beksac M; Zamagni E; Mark TM; Chari A; Elliott BM; Lowe VJ; Ozkan E; Nanni C
  • Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury.
    Food Chem Toxicol Volume: 50 Page(s): 1675 - 1679
    05/01/2012 Authors: Ulu R; Dogukan A; Tuzcu M; Gencoglu H; Ulas M; Ilhan N; Muqbil I; Mohammad RM; Kucuk O; Sahin K
  • Genistein inhibits highly proliferative hematopoietic stem cells
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Souza L; Silva E; Calloway E; Kucuk O; McLemore M
  • Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells.
    BMC Cancer Volume: 12 Page(s): 145
    04/11/2012 Authors: Phillip CJ; Giardina CK; Bilir B; Cutler DJ; Lai Y-H; Kucuk O; Moreno CS
  • EXTERNAL VALIDATION OF THE MODIFIED GLASGOW PROGNOSTIC SCORE (MGPS) FOR RENAL CANCER
    Volume: 187 Page(s): E680 - E680
    04/01/2012 Authors: Cross B; Johnson T; Kucuk O; Canter D; Pattaras J; Ogan K; Nieh P; Harris W; Master V
  • Utility of the modified Glasgow prognostic score in patients with metastatic renal cell carcinoma treated with targeted agents.
    J Clin Oncol Volume: 30 Page(s): 441
    02/10/2012 Authors: Akbashev MY; Lingerfelt BM; Liu Y; Kucuk O; Master VA; Harris W
  • External validation of the Glasgow prognostic score (mGPS) for renal cancer.
    J Clin Oncol Volume: 30 Page(s): 378
    02/10/2012 Authors: Master VA; Johnson TV; Kucuk O; Canter D; Pattaras J; Ogan K; Cross B; Nieh PT; Harris W
  • External validation of the Glasgow prognostic score (mGPS) for renal cancer.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 30
    02/10/2012 Authors: Master VA; Johnson TV; Kucuk O; Canter D; Pattaras J; Ogan K; Cross B; Nieh PT; Harris W
  • Utility of the modified Glasgow prognostic score in patients with metastatic renal cell carcinoma treated with targeted agents.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 30
    02/10/2012 Authors: Akbashev MY; Lingerfelt BM; Liu Y; Kucuk O; Master VA; Harris W
  • Utility of the modified Glasgow prognostic score in patients with metastatic renal cell carcinoma treated with targeted agents.
    J Clin Oncol Volume: 30 Page(s): 441
    02/10/2012 Authors: Akbashev MY; Lingerfelt BM; Liu Y; Kucuk O; Master VA; Harris W
  • External validation of the Glasgow prognostic score (mGPS) for renal cancer.
    J Clin Oncol Volume: 30 Page(s): 378
    02/10/2012 Authors: Master VA; Johnson TV; Kucuk O; Canter D; Pattaras J; Ogan K; Cross B; Nieh PT; Harris W
  • Selenium in the prevention of anthracycline-induced cardiac toxicity in children with cancer.
    J Oncol Volume: 2012 Page(s): 651630
    01/01/2012 Authors: Tacyildiz N; Ozyoruk D; Ozelci Kavas G; Yavuz G; Unal E; Dincaslan H; Atalay S; Ucar T; Ikinciogullari A; Doganay B
  • Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck.
    ISRN Oncol Volume: 2012 Page(s): 159568
    01/01/2012 Authors: Kafri Z; Heilbrun LK; Sukari A; Yoo G; Jacobs J; Lin H-S; Mulrenan H; Smith D; Kucuk O
  • Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy.
    Int J Surg Oncol Volume: 2012 Page(s): 524981
    01/01/2012 Authors: Cross BW; Johnson TV; Derosa AB; Ogan K; Pattaras JG; Nieh PT; Kucuk O; Harris WB; Master VA
  • Dietary agents in cancer chemoprevention and treatment.
    J Oncol Volume: 2012 Page(s): 749310
    01/01/2012 Authors: Raffoul JJ; Kucuk O; Sarkar FH; Hillman GG
  • Sensitization of Cervical Cancer Cells to Cisplatin by Genistein: The Role of NFB and Akt/mTOR Signaling Pathways.
    J Oncol Volume: 2012 Page(s): 461562
    01/01/2012 Authors: Sahin K; Tuzcu M; Basak N; Caglayan B; Kilic U; Sahin F; Kucuk O
  • PDGF upregulates Mcl-1 through activation of -catenin and HIF-1-dependent signaling in human prostate cancer cells.
    PLoS One Volume: 7 Page(s): e30764
    01/01/2012 Authors: Iqbal S; Zhang S; Driss A; Liu Z-R; Kim H-RC; Wang Y; Ritenour C; Zhau HE; Kucuk O; Chung LWK
  • EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis.
    Oncogene Volume: 30 Page(s): 4941 - 4952
    12/15/2011 Authors: Zhang S; Wang X; Osunkoya AO; Iqbal S; Wang Y; Chen Z; Mller S; Chen Z; Josson S; Coleman IM
  • Genistein Protects Against DNA Damage in Hematopoietic Stem Cells
    Volume: 118 Page(s): 1470 - 1470
    11/18/2011 Authors: Souza L; Silva E; Calloway E; Kucuk O; McLemore ML
  • Inhibitory effects of combination of lycopene and genistein on 7,12- dimethyl benz(a)anthracene-induced breast cancer in rats.
    Nutr Cancer Volume: 63 Page(s): 1279 - 1286
    11/01/2011 Authors: Sahin K; Tuzcu M; Sahin N; Akdemir F; Ozercan I; Bayraktar S; Kucuk O
  • Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.
    J Urol Volume: 186 Page(s): 1213 - 1217
    10/01/2011 Authors: Johnson TV; Ali S; Abbasi A; Kucuk O; Harris WB; Ogan K; Pattaras J; Nieh PT; Marshall FF; Osunkoya AO
  • Clinical trials of antioxidants as cancer prevention agents: past, present, and future.
    Free Radic Biol Med Volume: 51 Page(s): 1068 - 1084
    09/01/2011 Authors: Goodman M; Bostick RM; Kucuk O; Jones DP
  • Uses of questionnaire- and biomarker-based measures of pro- and antioxidant exposures in relation to prostate cancer risk
    Volume: 71
    04/15/2011 Authors: Kong SYJ; Goodman M; Kucuk O; Bostick RM
  • Simple perioperative algorithm for serum C-reactive protein: A potent, independent, adverse prognostic factor for renal cell carcinoma
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Harris WB; Lingerfelt BM; Chen Z; Kucuk O; Osunkoya AO; Pattaras JG; Ogan K; Nieh PT; Petros JA; Young AN
  • INTRATUMORAL C-REACTIVE PROTEIN AS A BIOMARKER OF PROGNOSIS IN LOCALIZED RENAL CELL CARCINOMA
    Volume: 185 Page(s): E667 - E668
    04/01/2011 Authors: Johnson T; Master V; Abbasi A; Kucuk O; Young A; Ogan K; Pattaras J; Nieh P; Marshall F; Osunkoya A
  • Use of preoperative erythrocyte sedimentation rate (ESR) to predict overall survival in localized renal cell carcinoma following radical nephrectomy.
    J Clin Oncol Volume: 29 Page(s): 361
    03/01/2011 Authors: Master VA; Kucuk O; Harris W; Cross B; Abbasi A; Michigan A; DeRosa A; Johnson TV; Marshall FF
  • Use of preoperative erythrocyte sedimentation rate (ESR) to predict overall survival in localized renal cell carcinoma following radical nephrectomy
    JOURNAL OF CLINICAL ONCOLOGY Volume: 29
    03/01/2011 Authors: Master VA; Kucuk O; Harris W; Cross B; Abbasi A; Michigan A; DeRosa A; Johnson TV; Marshall FF
  • Increased Expression of Intratumoral C-Reactive Protein Predicts Mortality in Patients with Localized Clear Cell Renal Cell Carcinoma.
    Volume: 24 Page(s): 176A - 176A
    02/01/2011 Authors: Ali S; Master VA; Abbasi A; Kucuk O; Young AN; Ogan K; Pattaras JG; Nieh PT; Marshall FF; Osunkoya AO
  • Increased Expression of Intratumoral C-Reactive Protein Predicts Mortality in Patients with Localized Clear Cell Renal Cell Carcinoma
    Volume: 91 Page(s): 176A - 176A
    02/01/2011 Authors: Ali S; Master VA; Abbasi A; Kucuk O; Young AN; Ogan K; Pattaras JG; Nieh PT; Marshall FF; Osunkoya AO
  • Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial.
    Nutr Cancer Volume: 63 Page(s): 889 - 898
    01/01/2011 Authors: Lazarevic B; Boezelijn G; Diep LM; Kvernrod K; Ogren O; Ramberg H; Moen A; Wessel N; Berg RE; Egge-Jacobsen W
  • Protective role of zinc picolinate on cisplatin-induced nephrotoxicity in rats.
    J Ren Nutr Volume: 20 Page(s): 398 - 407
    11/01/2010 Authors: Tuzcu M; Sahin N; Dogukan A; Aslan A; Gencoglu H; Ilhan N; Kucuk O; Sahin K
  • Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene.
    Food Chem Toxicol Volume: 48 Page(s): 2670 - 2674
    10/01/2010 Authors: Sahin K; Tuzcu M; Sahin N; Ali S; Kucuk O
  • Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma.
    Urology Volume: 76 Page(s): 766.e1 - 766.e5
    09/01/2010 Authors: Johnson TV; Abbasi A; Owen-Smith A; Young AN; Kucuk O; Harris WB; Osunkoya AO; Ogan K; Pattaras J; Nieh PT
  • Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats.
    Life Sci Volume: 87 Page(s): 240 - 245
    08/14/2010 Authors: Sahin K; Tuzcu M; Gencoglu H; Dogukan A; Timurkan M; Sahin N; Aslan A; Kucuk O
  • Soy Isoflavones in Prostate Cancer Treatment
    Volume: 42 Page(s): 24 - 24
    08/01/2010 Authors: Kucuk O
  • Cancer prevention with natural compounds.
    Semin Oncol Volume: 37 Page(s): 258 - 281
    06/01/2010 Authors: Gullett NP; Ruhul Amin ARM; Bayraktar S; Pezzuto JM; Shin DM; Khuri FR; Aggarwal BB; Surh Y-J; Kucuk O
  • A phase II trial of biweekly gemcitabine and paclitaxel (GEMTAX) combination in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group study
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Bickel KE; Worden FP; Moon J; Kucuk O; Wheeler RH; Clark J; Wolf GT; Urba S
  • Carotenoid and vitamin E levels in children with cancer
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Kucuk O; Tacyildiz N; Kose K; Dincaslan H; Yavuz G; Unal E; Ozyoruk D; Karatepe M; Suskan E; Sahin K
  • Effects of soy isoflavenes (genistein) on chemotherapy and radiotherapy toxicities in childhood cancer patients
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Tacyildiz N; Ozyoruk D; Yavuz G; Unal E; Dincaslan H; Dogu F; Sahin K; Kucuk O
  • POSTOPERATIVE BETTER THAN PREOPERATIVE C-REACTIVE PROTEIN AT PREDICTING OUTCOME FOLLOWING POTENTIALLY CURATIVE NEPHRECTOMY FOR RENAL CELL CARCINOMA
    Volume: 183 Page(s): E198 - E198
    04/01/2010 Authors: Master V; Johnson T; Abbasi A; Owen-Smith A; Young A; Kucuk O; Harris W; Osunkoye A; Ogan K; Pattaras J
  • Dietary zinc and prostate cancer in the TRAMP mouse model.
    J Med Food Volume: 13 Page(s): 70 - 76
    02/01/2010 Authors: Prasad AS; Mukhtar H; Beck FWJ; Adhami VM; Siddiqui IA; Din M; Hafeez BB; Kucuk O
  • Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.
    Nutr Cancer Volume: 62 Page(s): 996 - 1000
    01/01/2010 Authors: Ahmad IU; Forman JD; Sarkar FH; Hillman GG; Heath E; Vaishampayan U; Cher ML; Andic F; Rossi PJ; Kucuk O
  • Soy isoflavones ameliorate the adverse effects of chemotherapy in children.
    Nutr Cancer Volume: 62 Page(s): 1001 - 1005
    01/01/2010 Authors: Tacyildiz N; Ozyoruk D; Yavuz G; Unal E; Dincaslan H; Dogu F; Sahin K; Kucuk O
  • Lycopene and chemotherapy toxicity.
    Nutr Cancer Volume: 62 Page(s): 988 - 995
    01/01/2010 Authors: Sahin K; Sahin N; Kucuk O
  • Review on molecular and therapeutic potential of thymoquinone in cancer.
    Nutr Cancer Volume: 62 Page(s): 938 - 946
    01/01/2010 Authors: Banerjee S; Padhye S; Azmi A; Wang Z; Philip PA; Kucuk O; Sarkar FH; Mohammad RM
  • Second international congress on nutrition and cancer.
    Nutr Cancer Volume: 62 Page(s): 859
    01/01/2010 Authors: Kucuk O
  • The effects of selenium supplementation on the spontaneously occurring fibroid tumors of oviduct, 8-hydroxy-2'-deoxyguanosine levels, and heat shock protein 70 response in Japanese quail.
    Nutr Cancer Volume: 62 Page(s): 495 - 500
    01/01/2010 Authors: Tuzcu M; Sahin N; Ozercan I; Seren S; Sahin K; Kucuk O
  • Zinc picolinate in the prevention of leiomyoma in Japanese quail.
    J Med Food Volume: 12 Page(s): 1368 - 1374
    12/01/2009 Authors: Sahin N; Tuzcu M; Ozercan I; Sahin K; Prasad AS; Kucuk O
  • Effects of 25-hydroxycholecalciferol and soy isoflavones supplementation on bone mineralisation of quail.
    Br Poult Sci Volume: 50 Page(s): 709 - 715
    11/01/2009 Authors: Sahin N; Balci TA; Kucuk O; Smith MO; Sahin K
  • Role of dietary zinc in heat-stressed poultry: a review.
    Poult Sci Volume: 88 Page(s): 2176 - 2183
    10/01/2009 Authors: Sahin K; Sahin N; Kucuk O; Hayirli A; Prasad AS
  • Phase II clinical trial of zileuton in persons with bronchial dysplasia
    JOURNAL OF THORACIC ONCOLOGY Volume: 4 Page(s): S137 - S137
    09/01/2009 Authors: Kucuk O; Pass H; Lonardo F; Gazdar A; Madan S; Abrams J; Maddipati KR; Upfal M; Soubani AO; Honn K
  • Prostate Cancer: Case Study
    INTERNATIONAL JOURNAL OF UROLOGY Volume: 16 Page(s): 707 - 707
    08/01/2009 Authors: Menon M; Hara I; Kucuk O; Egawa S
  • Fourth joint meeting of the American Urological Association and the Japanese Urological Association Specialty Society program at the 104th annual meeting of the American Urological Association at Chicago 2009.
    Int J Urol Volume: 16 Page(s): 703 - 708
    08/01/2009 Authors: Cooperberg MR; Hinotsu S; Chancellor MB; Homma Y; Nelson PS; Matsuyama H; Menon M; Kucuk O; Hara I; Egawa S
  • Sinonasal mucosal melanoma: a 13-year experience at a single institution.
    Skull Base Volume: 19 Page(s): 255 - 262
    07/01/2009 Authors: Narasimhan K; Kucuk O; Lin H-S; Heilbrun LK; Carron M; Venkatramanamoorthy R; Mathog R
  • Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents.
    Cancer Lett Volume: 278 Page(s): 201 - 209
    06/18/2009 Authors: Ali S; Varghese L; Pereira L; Tulunay-Ugur OE; Kucuk O; Carey TE; Wolf GT; Sarkar FH
  • Perspectives for cancer prevention with natural compounds.
    J Clin Oncol Volume: 27 Page(s): 2712 - 2725
    06/01/2009 Authors: Amin ARMR; Kucuk O; Khuri FR; Shin DM
  • A phase II study examining the feasibility of long-term and low-dose oral capecitabine in newly diagnosed head and neck squamous cell carcinoma after surgery, radiation, and/or chemotherapy
    Volume: 27
    05/20/2009 Authors: Sukari A; Mulrenan H; Almhanna K; Kafri Z; Kim H; Ensley J; Kucuk O; Yoo G
  • A phase II study examining the feasibility of long-term and low-dose oral capecitabine in newly diagnosed head and neck squamous cell carcinoma after surgery, radiation, and/or chemotherapy.
    J Clin Oncol Volume: 27 Page(s): 6053
    05/20/2009 Authors: Sukari A; Mulrenan H; Almhanna K; Kafri Z; Kim H; Ensley J; Kucuk O; Yoo G
  • First International Congress on Nutrition and Cancer.
    Nutr Cancer Volume: 61 Page(s): 755
    01/01/2009 Authors: Kucuk O
  • Lycopene in the prevention of gastrointestinal toxicity of radiotherapy.
    Nutr Cancer Volume: 61 Page(s): 784 - 788
    01/01/2009 Authors: Andic F; Garipagaoglu M; Yurdakonar E; Tuncel N; Kucuk O
  • Genistein suppresses spontaneous oviduct tumorigenesis in quail.
    Nutr Cancer Volume: 61 Page(s): 799 - 806
    01/01/2009 Authors: Sahin K; Akdemir F; Tuzcu M; Sahin N; Onderci M; Ozercan R; Ilhan N; Kilic E; Seren S; Kucuk O
  • Cancer-induced cachexia: a guide for the oncologist.
    J Soc Integr Oncol Volume: 7 Page(s): 155 - 169
    01/01/2009 Authors: Gullett N; Rossi P; Kucuk O; Johnstone PAS
  • Zinc in cancer prevention.
    Nutr Cancer Volume: 61 Page(s): 879 - 887
    01/01/2009 Authors: Prasad AS; Beck FWJ; Snell DC; Kucuk O
  • Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease.
    Respir Med Volume: 102 Page(s): 840 - 844
    06/01/2008 Authors: Kirkil G; Hamdi Muz M; Sekin D; Sahin K; Kk O
  • Supplementation with organic or inorganic selenium in heat-distressed quail.
    Biol Trace Elem Res Volume: 122 Page(s): 229 - 237
    06/01/2008 Authors: Sahin N; Onderci M; Sahin K; Kucuk O
  • Chemoprevention of fibroid tumors by [-]-epigallocatechin-3-gallate in quail.
    Nutr Res Volume: 28 Page(s): 92 - 97
    02/01/2008 Authors: Ozercan IH; Sahin N; Akdemir F; Onderci M; Seren S; Sahin K; Kucuk O
  • The effects of tomato powder supplementation on performance and lipid peroxidation in quail.
    Poult Sci Volume: 87 Page(s): 276 - 283
    02/01/2008 Authors: Sahin N; Orhan C; Tuzcu M; Sahin K; Kucuk O
  • Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma.
    Nutr Cancer Volume: 60 Page(s): 729 - 735
    01/01/2008 Authors: Seren S; Mutchnick M; Hutchinson D; Harmanci O; Bayraktar Y; Mutchnick S; Sahin K; Kucuk O
  • Lycopene in cancer prevention and treatment.
    Am J Ther Volume: 15 Page(s): 66 - 81
    01/01/2008 Authors: Seren S; Lieberman R; Bayraktar UD; Heath E; Sahin K; Andic F; Kucuk O
  • Zinc in a combination with magnesium helps reducing negative effects of heat stress in quails.
    Biol Trace Elem Res Volume: 123 Page(s): 144 - 153
    01/01/2008 Authors: Kucuk O
  • Effect of soy isoflavone supplementation on prostate tissue, markers of proliferation and apoptosts and histopathological endpoints of tumor grade, volume and stage
    VIRCHOWS ARCHIV Volume: 451 Page(s): 412 - 412
    08/01/2007 Authors: Kupesiz GY; Sakr W; Cher M; Banerjee M; Pontes E; Parnes H; Kucuk O
  • Effects of high fruit-vegetable and/or low-fat intervention on breast nipple aspirate fluid micronutrient levels.
    Cancer Epidemiol Biomarkers Prev Volume: 16 Page(s): 1393 - 1399
    07/01/2007 Authors: Djuric Z; Chen G; Ren J; Venkatramanamoorthy R; Covington CY; Kucuk O; Heilbrun LK
  • The effect of soy isoflavones on egg quality and bone mineralisation during the late laying period of quail.
    Br Poult Sci Volume: 48 Page(s): 363 - 369
    06/01/2007 Authors: Sahin N; Onderci M; Balci TA; Cikim G; Sahin K; Kucuk O
  • Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
    Int J Cancer Volume: 120 Page(s): 2491 - 2498
    06/01/2007 Authors: Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
  • Mature results of a phase II trial of gemcitabine/paclitaxel given every 2 weeks in patients with advanced non-small-cell lung cancer.
    Clin Lung Cancer Volume: 8 Page(s): 313 - 318
    03/01/2007 Authors: Wozniak AJ; Belzer K; Heilbrun LK; Kucuk O; Gadgeel S; Kalemkerian GP; Venkatramanamoorthy R; Kraut MJ
  • Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck.
    Head Neck Volume: 29 Page(s): 267 - 271
    03/01/2007 Authors: Tulunay OE; Enamorado II; Kucuk O; Heilbrun LK; Otero JE; Korkmaz H; Blumberg R; Jacobs JR
  • Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model.
    BMC Cancer Volume: 7 Page(s): 4
    01/09/2007 Authors: Hillman GG; Wang Y; Che M; Raffoul JJ; Yudelev M; Kucuk O; Sarkar FH
  • Dietary tomato powder supplementation in the prevention of leiomyoma of the oviduct in the Japanese quail.
    Nutr Cancer Volume: 59 Page(s): 70 - 75
    01/01/2007 Authors: Sahin K; Ozercan R; Onderci M; Sahin N; Khachik F; Seren S; Kucuk O
  • Lycopene and soy isoflavones in the treatment of prostate cancer.
    Nutr Cancer Volume: 59 Page(s): 1 - 7
    01/01/2007 Authors: Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE
  • Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck.
    Head Neck Volume: 28 Page(s): 1090 - 1098
    12/01/2006 Authors: Shehadeh NJ; Ensley JF; Kucuk O; Black C; Yoo GH; Jacobs J; Lin H-S; Heilbrun LK; Smith D; Kim H
  • Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
    Radiat Res Volume: 166 Page(s): 73 - 80
    07/01/2006 Authors: Wang Y; Raffoul JJ; Che M; Doerge DR; Joiner MC; Kucuk O; Sarkar FH; Hillman GG
  • Phase II trial of weekly docetaxel and oral capecitabine in metastatic hormone-refractory prostate cancer.
    J Clin Oncol Volume: 24 Page(s): 4634
    06/20/2006 Authors: Marur S; Heilbrun L; Kucuk O; Cher ML; Forman J; Heath E; Vaishampayan U
  • Phase II trial of weekly docetaxel and oral capecitabine in metastatic hormone-refractory prostate cancer.
    Volume: 24 Page(s): 250S - 250S
    06/20/2006 Authors: Marur S; Heilbrun L; Kucuk O; Cher ML; Forman J; Heath E; Vaishampayan U
  • Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
    Cancer Res Volume: 66 Page(s): 4816 - 4825
    05/01/2006 Authors: Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
  • Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest.
    BMC Cancer Volume: 6 Page(s): 107
    04/26/2006 Authors: Raffoul JJ; Wang Y; Kucuk O; Forman JD; Sarkar FH; Hillman GG
  • Effects of dietary genistein on nutrient use and mineral status in heat-stressed quails.
    Exp Anim Volume: 55 Page(s): 75 - 82
    04/01/2006 Authors: Sahin N; Sahin K; Onderci M; Sarkar FH; Doerge D; Prasad A; Kucuk O
  • Does contrast medium administration in organ donors affect early kidney graft function?
    Transplant Proc Volume: 38 Page(s): 668 - 669
    04/01/2006 Authors: Grosse K; Brauer B; Kck O; Krger R; Polster F; Grauhan O; Wesslau C
  • Dietary arginine silicate inositol complex during the late laying period of quail at different environmental temperatures.
    Br Poult Sci Volume: 47 Page(s): 209 - 215
    04/01/2006 Authors: Onderci M; Sahin N; Sahin K; Balci TA; Gursu MF; Juturu V; Kucuk O
  • Characterization of a HER2/neu over-expressing lobular carcinoma and mechanisms contributing to the therapeutic efficacy of Iressa in vitro and in vivo.
    Volume: 66
    04/01/2006 Authors: Piechocki MP; Dibbley SK; Kucuk O
  • Soy is a safe and potent radiosensitizer for prostate cancer in vitro and in vivo compared to pure genistein.
    Volume: 66
    04/01/2006 Authors: Raffoul JJ; Banerjee S; Knoll ZE; Che M; Kucuk O; Sarkar FH; Hillman GG
  • Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.
    Cancer Volume: 106 Page(s): 1260 - 1268
    03/15/2006 Authors: Mohammad RM; Banerjee S; Li Y; Aboukameel A; Kucuk O; Sarkar FH
  • Dietary arginine silicate inositol complex improves bone mineralization in quail.
    Poult Sci Volume: 85 Page(s): 486 - 492
    03/01/2006 Authors: Sahin K; Onderci M; Sahin N; Balci TA; Gursu MF; Juturu V; Kucuk O
  • Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.
    Nucl Med Commun Volume: 27 Page(s): 261 - 266
    03/01/2006 Authors: Kk ON; Gltekin SS; Aras G; Ibi E
  • An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels.
    J AOAC Int Volume: 89 Page(s): 1121 - 1134
    01/01/2006 Authors: Messina M; Kucuk O; Lampe JW
  • Transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischemic cardiomyopathy; Safety, efficacy and outcome.
    CYTOTHERAPY Volume: 8
    01/01/2006 Authors: Akar R; Durdu S; Arat M; Kucuk ON; Kilickap M; Ozcinar E; Eren NT; Arslan O; Yazicioglu L; Tasoz R
  • The value of soy isoflavones in modulating biomarkers of growth and differentiation in breast cancer
    Volume: 86 Page(s): 21A - 21A
    01/01/2006 Authors: Basturk O; Adsay NV; Banerjee M; Newman L; Bouwman D; Doerge D; Djuric Z; Parchment R; Majundar A; Miller F
  • The value of soy isoflavones in modulating biomarkers of growth and differentiation in breast cancer
    Volume: 19 Page(s): 21A - 21A
    01/01/2006 Authors: Basturk O; Adsay NV; Banerjee M; Newman L; Bouwman D; Doerge D; Djuric Z; Parchment R; Majumdar A; Miller F
  • Serum brain derived neurotrophic factor levels in schizophrenic patients treated with olanzapine and clozapine
    Volume: 15 Page(s): S492 - S492
    10/01/2005 Authors: Pirildar S; Taneli F; Mete L; Gonul AS; Kucuk O; Zorlu N
  • Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
    Cancer Res Volume: 65 Page(s): 6934 - 6942
    08/01/2005 Authors: Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
  • Effects of dietary combination of chromium and biotin on growth performance, carcass characteristics, and oxidative stress markers in heat-distressed Japanese quail.
    Biol Trace Elem Res Volume: 106 Page(s): 165 - 176
    08/01/2005 Authors: Onderci M; Sahin K; Sahin N; Cikim G; Vijaya J; Kucuk O
  • Chromium picolinate, rather than biotin, alleviates performance and metabolic parameters in heat-stressed quail.
    Br Poult Sci Volume: 46 Page(s): 457 - 463
    08/01/2005 Authors: Sahin N; Sahin K; Onderci M; Gursu MF; Cikim G; Vijaya J; Kucuk O
  • Magnesium proteinate is more protective than magnesium oxide in heat-stressed quail.
    J Nutr Volume: 135 Page(s): 1732 - 1737
    07/01/2005 Authors: Sahin N; Onderci M; Sahin K; Cikim G; Kucuk O
  • Interim report: A phase III randomized double blind chemoprevention trial of selenium supplementation in persons with resected stage I non small cell lung cancer
    Volume: 49 Page(s): S181 - S181
    07/01/2005 Authors: Karp D; Lee S; Keller S; Johnson D; Kucuk O; Clamon G; Marks R; Johnston M; Okawara G; Ruckdeschel J
  • Supplementation of zinc from organic or inorganic source improves performance and antioxidant status of heat-distressed quail.
    Poult Sci Volume: 84 Page(s): 882 - 887
    06/01/2005 Authors: Sahin K; Smith MO; Onderci M; Sahin N; Gursu MF; Kucuk O
  • Regional cerebral blood flow in children with ADHD: changes with age.
    Brain Dev Volume: 27 Page(s): 279 - 285
    06/01/2005 Authors: Oner O; Oner P; Aysev A; Kk O; Ibis E
  • EGFR-related protein (ERRP) inhibits multiple members of EGFR family in colon, lung and breast cancer cells
    Volume: 128 Page(s): A78 - A78
    04/01/2005 Authors: Xu H; Yu YJ; Khan A; Marciniak D; Rishi A; Sarkar F; Kucuk O; Majumdar AP
  • EGFR-related protein (ERRP) inhibits multiple members of EGFR family in colon, lung and breast cancer cells
    Volume: 19 Page(s): A553 - A553
    03/04/2005 Authors: Xu H; Yu YJ; Khan A; Marciniak D; Rishi AK; Sarkar FH; Kucuk O; Majumdar APN
  • Effect of arginine silicate inositol complex on bone mineralization
    Volume: 19 Page(s): A57 - A57
    03/04/2005 Authors: Sahin K; Onderci M; Sahin N; Balci TA; Gursu MF; Juturu V; Kucuk O
  • Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
    Mol Cancer Ther Volume: 4 Page(s): 435 - 442
    03/01/2005 Authors: Xu H; Yu Y; Marciniak D; Rishi AK; Sarkar FH; Kucuk O; Majumdar APN
  • Transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy: safety, efficacy and outcome
    Volume: 35 Page(s): S76 - S76
    03/01/2005 Authors: Akar AR; Durdu S; Arat M; Topcuoglu P; Kucuk O; Kilickap M; Gulev B; Eren NT; Arslan O; Corapcioglu T
  • The effect of genistein supplementation on performance and antioxidant status of Japanese quail under heat stress.
    Arch Anim Nutr Volume: 58 Page(s): 463 - 471
    12/01/2004 Authors: Onderci M; Sahin K; Sahin N; Gursu MF; Doerge D; Sarkar FH; Kucuk O
  • Incidence of bronchial dysplasia in cohorts identified via different screening strategies.
    Volume: 13 Page(s): 1831S - 1831S
    11/01/2004 Authors: Szabo E; Lam S; Kucuk O; Mao J; McWilliams A; leRiche J; MacAulay C; Pas H; Stevens T; Madan S
  • Chemosensitization of cancer cells by soy isoflavone genistein, a chemopreventive agent, is mediated by inactivation of NF-kappa B activity.
    Volume: 13 Page(s): 1833S - 1833S
    11/01/2004 Authors: Li YW; Ahmad F; Ellis KL; Kucuk O; Philip PA; Sarkar FH
  • Correlation of histopathological variants, cellular DNA content, and clinical outcome in adenoid cystic carcinoma of the salivary glands.
    Otolaryngol Head Neck Surg Volume: 131 Page(s): 646 - 650
    11/01/2004 Authors: Enamorado I; Lakhani R; Korkmaz H; Yoo GH; Del Mar Alonso M; Pietraszkiewicz H; Maciorowski Z; Kim H; Kucuk O; Jacobs JR
  • Effects of dietary combination of chromium and biotin on egg production, serum metabolites, and egg yolk mineral and cholesterol concentrations in heat-distressed laying quails.
    Biol Trace Elem Res Volume: 101 Page(s): 181 - 192
    11/01/2004 Authors: Sahin K; Onderci M; Sahin N; Gursu MF; Vijaya J; Kucuk O
  • I-131 therapy for thyroglobulin positive patients without anatomical evidence of persistent disease.
    J Endocrinol Invest Volume: 27 Page(s): 949 - 953
    11/01/2004 Authors: Kamel N; Corapcioglu D; Sahin M; Grsoy A; Kk O; Aras G
  • Strategies for accrual of subjects with bronchial dysplasia for a lung cancer prevention study.
    Volume: 13 Page(s): 1937S - 1938S
    11/01/2004 Authors: Upfal M; Harvey P; Lonardo F; Madan S; Stevens T; Moore M; Szabo E; Kucuk O
  • Antioxidant effect of zinc in humans.
    Free Radic Biol Med Volume: 37 Page(s): 1182 - 1190
    10/15/2004 Authors: Prasad AS; Bao B; Beck FWJ; Kucuk O; Sarkar FH
  • Soybean oil supplementation of a high-concentrate diet does not affect site and extent of organic matter, starch, neutral detergent fiber, or nitrogen digestion, but influences both ruminal metabolism and intestinal flow of fatty acids in limit-fed lambs.
    J Anim Sci Volume: 82 Page(s): 2985 - 2994
    10/01/2004 Authors: Kucuk O; Hess BW; Rule DC
  • Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model.
    Mol Cancer Ther Volume: 3 Page(s): 1271 - 1279
    10/01/2004 Authors: Hillman GG; Wang Y; Kucuk O; Che M; Doerge DR; Yudelev M; Joiner MC; Marples B; Forman JD; Sarkar FH
  • Expression of epidermal growth factor-receptor related protein (ERRP) in human colorectal carcinogenesis.
    Cancer Lett Volume: 213 Page(s): 249 - 255
    09/30/2004 Authors: Jaszewski R; Levi E; Sochacki P; Frank J; Kucuk O; Axelrod BN; Majumdar APN
  • Folic acid-mediated inhibition of serum-induced activation of EGFR promoter in colon cancer cells.
    Am J Physiol Gastrointest Liver Physiol Volume: 287 Page(s): G541 - G546
    09/01/2004 Authors: Nagothu KK; Rishi AK; Jaszewski R; Kucuk O; Majumdar APN
  • Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein
    Volume: 19 Page(s): 1593 - 1594
    09/01/2004 Authors: Cher ML; Li YW; Che MX; Bhagat S; Ellis KL; Kucuk O; Doerge DR; Abrams J; Sarkar FH
  • Unknown head and neck primary: Treatment with neck dissection followed by concurrent chemoradiotherapy.
    Volume: 22 Page(s): 495S - 495S
    07/15/2004 Authors: Shehadeh NJ; Becker M; Yoo G; Lin HS; Jacobs J; Mathog R; Kucuk O; Kim H; Black C; Ensley J
  • Cytochrome p450 and glutathione transferase expression in squamous cell cancer.
    Clin Cancer Res Volume: 10 Page(s): 4412 - 4416
    07/01/2004 Authors: Ali S; El-Rayes BF; Heilbrun LK; Sarkar FH; Ensley JF; Kucuk O; Philip PA
  • Clinical trial of soy Isoflavones before breast cancer surgery.
    Volume: 134 Page(s): 1262S - 1262S
    05/01/2004 Authors: Kucuk O; Sarkar F; Adsay V; Newman L; Bouwman D; Djuric Z; Doerge D; Parchment R; Banerjee M; Majumdar A
  • Genistein and tamoxifen interaction in MCF10DCIS.corn xenograft model for chemoprevention.
    Volume: 134 Page(s): 1261S - 1261S
    05/01/2004 Authors: Miller FR; Tait LR; Doerge D; Sarkar F; Kucuk O
  • Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line.
    Pancreas Volume: 28 Page(s): e90 - e95
    05/01/2004 Authors: Li Y; Ellis K-L; Ali S; El-Rayes BF; Nedeljkovic-Kurepa A; Kucuk O; Philip PA; Sarkar FH
  • Genistein sensitizes resistant diffuse large cell lymphoma cells to chemotherapy.
    Volume: 134 Page(s): 1264S - 1264S
    05/01/2004 Authors: Mohammad R; Al-Katib A; Aboukameel A; Ibrahim D; Doerge D; Sarkar F; Kucuk O
  • Genistein differentially regulates prostate-enriched protein expression in prostate cancer
    Volume: 134 Page(s): 1258S - 1258S
    05/01/2004 Authors: Lazarevic B; Karlsen S; Kucuk O; Saatcioglu F
  • Genistein and EGFR related protein (ERRP) potentiate each other in gastric, colon and prostate cancer cells.
    Volume: 134 Page(s): 1263S - 1264S
    05/01/2004 Authors: Kodali U; Kucuk O; Jaszewski R; Levi E; Doerge D; Sarkar F; Majumdar APN
  • Radiosensitization by genistein in an orthotopic mouse model of prostate cancer.
    Volume: 134 Page(s): 1241S - 1242S
    05/01/2004 Authors: Hillman GG; Kucuk O; Wang Y; Che M; Wright J; Joiner MC; Marples B; Yudelev M; Forman JD; Sarkar FH
  • Soy isoflavones and lycopene in the treatment of hormone-sensitive and hormone-refractory prostate cancer.
    Volume: 134 Page(s): 1258S - 1258S
    05/01/2004 Authors: Vaishampayan UV; Forman JJ; Hussain M; Cher M; Pontes E; Fontana J; Alluri KC; Doerge D; Sarkar F; Kucuk O
  • An in vitro model of chronic soy isoflavone exposure.
    Volume: 134 Page(s): 1261S - 1262S
    05/01/2004 Authors: Schwartz JA; Kucuk O; Gerard BS; Siramanne T; Dryer B
  • Paclitaxel-induced growth arrest in breast cancer is enhanced by genistein.
    Volume: 134 Page(s): 1261S - 1261S
    05/01/2004 Authors: Schwartz JA; Kucuk O; Gerard BS
  • Potentiation of radiation-induced cell killing by genistein in prostate cancer cells in vitro.
    Volume: 134 Page(s): 1258S - 1259S
    05/01/2004 Authors: Hillman GG; Kucuk O; Joiner MC; Marples B; Wang Y; Wright JL; Ellis KL; Yudelev M; Forman JD; Sarkar FH
  • Soy isoflavone genistein inhibits NF-kappa B and sensitizes human cancer cells to apoptosis induced by chemotherapeutic agents.
    Volume: 134 Page(s): 1242S - 1242S
    05/01/2004 Authors: Li Y; Ellis KL; Nedeljkovic-Kurepa A; Kucuk O; Sarkar FH
  • Genistein supplementation alleviates the deterioration in performance and antioxidant status of Japanese quail associated with heat stress.
    Volume: 134 Page(s): 1266S - 1267S
    05/01/2004 Authors: Sahin K; Onderci M; Gursu MF; Sahin N; Doerge D; Sarkar F; Kucuk O
  • Clinical trial of soy isoflavone supplementation before radical prostatectomy in patients with localized prostate cancer.
    Volume: 134 Page(s): 1258S - 1258S
    05/01/2004 Authors: Kucuk O; Sarkar F; Sakr W; Wood D; Cher M; Abrams J; Doerge DD; Pollak MM; Djuric Z; Majumdar A
  • Effects of dietary genistein on nutrient use and mineral status in heat-stressed quail.
    Volume: 134 Page(s): 1288S - 1288S
    05/01/2004 Authors: Sahin K; Sahin N; Onderci M; Sarkar FF; Prasad A; Doerge D; Kucuk O
  • Soy isoflavone genistein inhibits nuclear factor-kappa B and sensitizes human cancer cells to apoptosis induced by chemotherapeutic agents.
    Volume: 134 Page(s): 1265S - 1265S
    05/01/2004 Authors: Li Y; Ellis K; Nedeljkovic-Kurepa A; Kucuk O; Sarkar F
  • Genistein does not sensitize human bone marrow to XK469 toxicity at concentrations that sensitize BxPC3 pancreatic cancer to XK469 chemotherapy.
    Volume: 134 Page(s): 1264S - 1264S
    05/01/2004 Authors: Parchment RE; Sarkar F; Kassab J; Ellis KL; Doerge D; Kucuk O
  • Folic acid reduces nuclear translocation of beta-catenin in rectal mucosal crypts of patients with colorectal adenomas.
    Cancer Lett Volume: 206 Page(s): 27 - 33
    03/31/2004 Authors: Jaszewski R; Millar B; Hatfield JS; Nogothu K; Finkenauer R; Rishi AK; Naumoff JA; Kucuk O; Axelrod BN; Majumdar APN
  • Effects of dietary combination of chromium and biotin on growth performance, meat quality and oxidative stress markers in heat distressed Japanese quail
    Volume: 18 Page(s): A914 - A914
    03/24/2004 Authors: Kazim S; Onderci M; Sahin N; Cikim G; Juturu V; Kucuk O
  • The effects of Dietary Combination of Chromium and Biotin on egg production, serum metabolites, and egg yolk mineral and cholesterol concentrations in heat-distressed laying quails
    Volume: 18 Page(s): A913 - A914
    03/24/2004 Authors: Kazim S; Onderci M; Sahin N; Cikim G; Juturu V; Kucuk O
  • Lycopene supplementation prevents the development of spontaneous smooth muscle tumors of the oviduct in Japanese quail
    Volume: 18 Page(s): A11 - A11
    03/23/2004 Authors: Kazim S; Ozercan R; Onderci M; Sahin N; Gursu MF; Khachik F; Sarkar F; Munkarah A; Ali R; Kmak D
  • Differential expression of hZnT-4 in human prostate tissues.
    Prostate Volume: 58 Page(s): 374 - 381
    03/01/2004 Authors: Beck FWJ; Prasad AS; Butler CE; Sakr WA; Kucuk O; Sarkar FH
  • Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.
    Neoplasia Volume: 6 Page(s): 354 - 363
    01/01/2004 Authors: Li Y; Che M; Bhagat S; Ellis K-L; Kucuk O; Doerge DR; Abrams J; Cher ML; Sarkar FH
  • Lycopene supplementation prevents the development of spontaneous smooth muscle tumors of the oviduct in Japanese quail.
    Nutr Cancer Volume: 50 Page(s): 181 - 189
    01/01/2004 Authors: Sahin K; Ozercan R; Onderci M; Sahin N; Gursu MF; Khachik F; Sarkar FH; Munkarah A; Ali-Fehmi R; Kmak D
  • EGF-receptor related protein causes cell cycle arrest and induces apoptosis of colon cancer cells in vitro and in vivo.
    Anticancer Res Volume: 24 Page(s): 2885 - 2891
    01/01/2004 Authors: Levi E; Mohammad R; Kodali U; Marciniak D; Reddy S; Aboukameel A; Sarkar FH; Kucuk O; Rishi AK; Majumdar APN
  • Soy isoflavones in the treatment of prostate cancer
    Page(s): 695 - 700
    01/01/2004 Authors: Kucuk O
  • Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy.
    Mol Cancer Ther Volume: 2 Page(s): 1361 - 1368
    12/01/2003 Authors: Mohammad RM; Al-Katib A; Aboukameel A; Doerge DR; Sarkar F; Kucuk O
  • Zinc supplementation alleviates heat stress in laying Japanese quail.
    J Nutr Volume: 133 Page(s): 2808 - 2811
    09/01/2003 Authors: Sahin K; Kucuk O
  • Supplemental zinc and vitamin A can alleviate negative effects of heat stress in broiler chickens.
    Biol Trace Elem Res Volume: 94 Page(s): 225 - 235
    09/01/2003 Authors: Kucuk O; Sahin N; Sahin K
  • Dietary vitamin C and folic acid supplementation ameliorates the detrimental effects of heat stress in Japanese quail.
    J Nutr Volume: 133 Page(s): 1882 - 1886
    06/01/2003 Authors: Sahin K; Onderci M; Sahin N; Gursu MF; Kucuk O
  • Expression of EGF-receptor related protein (ERRP) decreases in gastric mucosa during aging and carcinogenesis.
    Dig Dis Sci Volume: 48 Page(s): 856 - 864
    05/01/2003 Authors: Majumdar APN; Du J; Hatfield JS; Levi E; Adsay V; Schmelz EM; Nagothu KK; Jaszewski R; Kucuk O; Sarkar FH
  • Regulation of EGF-receptor (EGFR) in the gastric mucosa during aging and carcinogenesis by ERRP, a novel negative regulator of EGFR
    Volume: 124 Page(s): A273 - A273
    04/01/2003 Authors: Majumdar APN; Du JH; Nagothu KK; Hatfield J; Levi E; Adsay V; Schmelz EM; Rishi AK; Jaszewski R; Kucuk O
  • Oral preneoplasia and chemoprevention of squamous cell carcinoma of the head and neck.
    Cancer Treat Res Volume: 114 Page(s): 61 - 83
    01/01/2003 Authors: Kucuk O
  • Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas.
    Cancer Detect Prev Volume: 27 Page(s): 297 - 304
    01/01/2003 Authors: Nagothu KK; Jaszewski R; Moragoda L; Rishi AK; Finkenauer R; Tobi M; Naumoff JA; Dhar R; Ehrinpreis M; Kucuk O
  • Soy isoflavones in the treatment of prostate cancer.
    Nutr Cancer Volume: 47 Page(s): 111 - 117
    01/01/2003 Authors: Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J
  • Effects of lycopene supplementation in patients with localized prostate cancer.
    Exp Biol Med (Maywood) Volume: 227 Page(s): 881 - 885
    11/01/2002 Authors: Kucuk O; Sarkar FH; Djuric Z; Sakr W; Pollak MN; Khachik F; Banerjee M; Bertram JS; Wood DP
  • Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells.
    Mol Carcinog Volume: 34 Page(s): 91 - 101
    06/01/2002 Authors: Davis JN; Kucuk O; Sarkar FH
  • Effects of vitamin C and vitamin E on lipid peroxidation status, serum hormone, metabolite, and mineral concentrations of Japanese quails reared under heat stress (34 degrees C).
    Int J Vitam Nutr Res Volume: 72 Page(s): 91 - 100
    03/01/2002 Authors: Sahin K; Kucuk O; Sahin N; Sari M
  • Soy isoflavones in the treatment of prostate cancer.
    JOURNAL OF NUTRITION Volume: 132 Page(s): 575S - 576S
    03/01/2002 Authors: Hussain M; Sarkar FH; Djuric Z; Pollak MN; Banerjee M; Doerge D; Fontana J; Chinni S; Davis J; Forman J
  • Re: Response of hormone refractory prostate cancer to lycopene.
    J Urol Volume: 167 Page(s): 651
    02/01/2002 Authors: Kucuk O; Wood DP
  • Response of hormone refractory prostate cancer to lycopene
    JOURNAL OF UROLOGY Volume: 167 Page(s): 651 - 651
    02/01/2002 Authors: Kucuk O; Wood DP
  • Methods to increase fruit and vegetable intake with and without a decrease in fat intake: compliance and effects on body weight in the nutrition and breast health study.
    Nutr Cancer Volume: 43 Page(s): 141 - 151
    01/01/2002 Authors: Djuric Z; Poore KM; Depper JB; Uhley VE; Lababidi S; Covington C; Klurfeld DM; Simon MS; Kucuk O; Heilbrun LK
  • Zinc in cancer prevention.
    Cancer Metastasis Rev Volume: 21 Page(s): 291 - 295
    01/01/2002 Authors: Prasad AS; Kucuk O
  • Cancer chemoprevention.
    Cancer Metastasis Rev Volume: 21 Page(s): 189 - 197
    01/01/2002 Authors: Kucuk O
  • Chemoprevention of prostate cancer.
    Cancer Metastasis Rev Volume: 21 Page(s): 111 - 124
    01/01/2002 Authors: Kucuk O
  • Effects of dietary chromium and ascorbic acid supplementation on digestion of nutrients, serum antioxidant status, and mineral concentrations in laying hens reared at a low ambient temperature.
    Biol Trace Elem Res Volume: 87 Page(s): 113 - 124
    01/01/2002 Authors: Sahin K; Sahin N; Kucuk O
  • New opportunities in chemoprevention research.
    Cancer Invest Volume: 20 Page(s): 237 - 245
    01/01/2002 Authors: Kucuk O
  • Effects of vitamin E and selenium on performance, digestibility of nutrients, and carcass characteristics of Japanese quails reared under heat stress (34 degrees C).
    J Anim Physiol Anim Nutr (Berl) Volume: 85 Page(s): 342 - 348
    12/01/2001 Authors: Sahin K; Kucuk O
  • Effects of vitamin C and vitamin E on performance, digestion of nutrients and carcass characteristics of Japanese quails reared under chronic heat stress (34 degrees C).
    J Anim Physiol Anim Nutr (Berl) Volume: 85 Page(s): 335 - 341
    12/01/2001 Authors: Sahin K; Kucuk O
  • Effect of soy isoflavone supplementation on markers of oxidative stress in men and women.
    Cancer Lett Volume: 172 Page(s): 1 - 6
    10/22/2001 Authors: Djuric Z; Chen G; Doerge DR; Heilbrun LK; Kucuk O
  • Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
    Cancer Epidemiol Biomarkers Prev Volume: 10 Page(s): 861 - 868
    08/01/2001 Authors: Kucuk O; Sarkar FH; Sakr W; Djuric Z; Pollak MN; Khachik F; Li YW; Banerjee M; Grignon D; Bertram JS
  • Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235).
    Urology Volume: 58 Page(s): 53 - 58
    07/01/2001 Authors: Kucuk O; Fisher E; Moinpour CM; Coleman D; Hussain MH; Sartor AO; Chatta GS; Lowe BA; Eisenberger MA; Crawford ED
  • Effects of dietary chromium picolinate supplementation on performance and plasma concentrations of insulin and corticosterone in laying hens under low ambient temperature.
    J Anim Physiol Anim Nutr (Berl) Volume: 85 Page(s): 142 - 147
    06/01/2001 Authors: Sahin K; Kk O; Sahin N
  • Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes.
    Free Radic Biol Med Volume: 30 Page(s): 1293 - 1302
    06/01/2001 Authors: Davis JN; Kucuk O; Djuric Z; Sarkar FH
  • Antioxidant dietary supplements: Rationale and current status as chemopreventive agents for prostate cancer.
    Urology Volume: 57 Page(s): 90 - 94
    04/01/2001 Authors: Fleshner NE; Kucuk O
  • Genistein potentiates the radiation effect on prostate carcinoma cells.
    Clin Cancer Res Volume: 7 Page(s): 382 - 390
    02/01/2001 Authors: Hillman GG; Forman JD; Kucuk O; Yudelev M; Maughan RL; Rubio J; Layer A; Tekyi-Mensah S; Abrams J; Sarkar FH
  • A simple way to reduce heat stress in laying hens as judged by egg laying, body weight gain and biochemical parameters.
    Acta Vet Hung Volume: 49 Page(s): 421 - 430
    01/01/2001 Authors: Sahin K; Kk O
  • Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia.
    Am J Clin Oncol Volume: 23 Page(s): 379 - 383
    08/01/2000 Authors: Kucuk O; Kilton L; Wade JL; Blough R; Benson AB
  • Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
    Am J Clin Oncol Volume: 23 Page(s): 371 - 375
    08/01/2000 Authors: Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
  • Phase II trail of didemnin B in previously treated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group (ECOG) Study.
    Am J Clin Oncol Volume: 23 Page(s): 273 - 277
    06/01/2000 Authors: Kucuk O; Young ML; Habermann TM; Wolf BC; Jimeno J; Cassileth PA
  • Inhibition of prostate specific antigen expression by genistein in prostate cancer cells.
    Int J Oncol Volume: 16 Page(s): 1091 - 1097
    06/01/2000 Authors: Davis JN; Muqim N; Bhuiyan M; Kucuk O; Pienta KJ; Sarkar FH
  • Folic acid inhibition of EGFR-mediated proliferation in human colon cancer cell lines.
    Am J Physiol Volume: 277 Page(s): C1142 - C1148
    12/01/1999 Authors: Jaszewski R; Khan A; Sarkar FH; Kucuk O; Tobi M; Zagnoon A; Dhar R; Kinzie J; Majumdar AP
  • Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
    Cancer Volume: 86 Page(s): 2364 - 2369
    12/01/1999 Authors: Hussain M; Gadgeel S; Kucuk O; Du W; Salwen W; Ensley J
  • Genistein inhibits NF-kappa B activation in prostate cancer cells.
    Nutr Cancer Volume: 35 Page(s): 167 - 174
    01/01/1999 Authors: Davis JN; Kucuk O; Sarkar FH
  • Nutritional and zinc status of head and neck cancer patients: an interpretive review.
    J Am Coll Nutr Volume: 17 Page(s): 409 - 418
    10/01/1998 Authors: Prasad AS; Beck FW; Doerr TD; Shamsa FH; Penny HS; Marks SC; Kaplan J; Kucuk O; Mathog RH
  • Phase changes in membrane lipids in sickle red cell shed-vesicles and sickle red cells.
    Am J Hematol Volume: 58 Page(s): 177 - 182
    07/01/1998 Authors: Westerman MP; Unger L; Kucuk O; Quinn P; Lis LJ
  • Folic acid: Regulation of growth of colon and gastric cancer cell lines.
    GASTROENTEROLOGY Volume: 114 Page(s): A567 - A567
    04/15/1998 Authors: Boppana SB; Sarkar FH; Liu L; Li YW; Khan A; Kucuk O; Mahakala K; Jaszewski R; Majumdar APN; Bertram JS
  • Effects of beta-carotene and alpha-tocopherol on bleomycin-induced chromosomal damage.
    Cancer Epidemiol Biomarkers Prev Volume: 7 Page(s): 113 - 117
    02/01/1998 Authors: Goodman MT; Hernandez B; Wilkens LR; Lee J; Le Marchand L; Liu LQ; Franke AA; Kk O; Hsu TC
  • Digital ischemia and gangrene due to red blood cell aggregation induced by acquired dysfibrinogenemia.
    J Vasc Surg Volume: 26 Page(s): 1061 - 1068
    12/01/1997 Authors: Kwaan HC; Levin M; Sakurai S; Kucuk O; Rooney MW; Lis LJ; Kauffman JW
  • Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.
    Semin Oncol Volume: 24 Page(s): S19-43-S19-45
    12/01/1997 Authors: Hussain M; Salwen W; Kucuk O; Ensley J
  • A novel acquired dysfibrinogenemia producing red cell aggregation and digital ischemia.
    BLOOD Volume: 90 Page(s): 2088 - 2088
    11/15/1997 Authors: Kwaan HC; Takahashi K; Sakurai S; Levin M; Kucuk O; Rooney MW; Lis LJ; Kaufman JW
  • Connexin 43 (Cx 43): A marker for early neoplastic transformation in squamous neoplasia of the upper aerodigestive tract (uadt).
    LABORATORY INVESTIGATION Volume: 76 Page(s): 679 - 679
    01/01/1997 Authors: Sakr WA; Crissman JD; Sarkar FH; Tabaczka P; Kucuk O; Bertrram J
  • Reproducibility of erythrocyte polyamine measurements and correlation with plasma micronutrients in an antioxidant vitamin intervention study (vol 62, pg 19, 1996)
    JOURNAL OF CELLULAR BIOCHEMISTRY Volume: 63 Page(s): 123 - 123
    10/01/1996 Authors: Wang W; Kucuk O; Franke AA; Liu LQ; Custer LJ; Higuchi CM
  • Reproducibility of erythrocyte polyamine measurements and correlation with plasma micronutrients in an antioxidant vitamin intervention study.
    J Cell Biochem Volume: 62 Page(s): 19 - 26
    07/01/1996 Authors: Wang W; Kucuk O; Franke AA; Liu LQ; Custer LJ; Higuchi CM
  • Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.
    Am J Clin Oncol Volume: 18 Page(s): 318 - 324
    08/01/1995 Authors: Clark JL; Kk O; Neuberg DS; Benson AB; Taylor SG; Pandya KJ; Mansour EG; Douglass HO; Haller DG
  • Real-time X-ray diffraction study at different scan rates of phase transitions for dipalmitoylphosphatidylcholine in KSCN.
    Biochim Biophys Acta Volume: 1233 Page(s): 68 - 74
    01/26/1995 Authors: Cunningham BA; Quinn PJ; Wolfe DH; Tamura-Lis W; Lis LJ; Kucuk O; Westerman MP
  • Sterols stabilize the ripple phase structure in dihexadecylphosphatidylcholine.
    Biochim Biophys Acta Volume: 1233 Page(s): 75 - 83
    01/26/1995 Authors: Cunningham BA; Midmore L; Kucuk O; Lis LJ; Westerman MP; Bras W; Wolfe DH; Quinn PJ; Qadri SB
  • Flow cytometric measurement of proliferation-associated nuclear antigen P105 and DNA content in immuno-proliferative small intestinal disease (IPSID).
    J Surg Oncol Volume: 58 Page(s): 25 - 30
    01/01/1995 Authors: Demirer T; Uzunalimoglu O; Anderson T; Koethe SM; McFadden PW; Demirer S; Uzunalimoglu B; Kucuk O
  • Correlations between mutagen sensitivity and plasma nutrient levels of healthy individuals.
    Cancer Epidemiol Biomarkers Prev Volume: 4 Page(s): 217 - 221
    01/01/1995 Authors: Kk O; Pung A; Franke AA; Custer LJ; Wilkens LR; Le Marchand L; Higuchi CM; Cooney RV; Hsu TC
  • Inhibition of cytolytic T lymphocyte activity by oxysterols.
    Lipids Volume: 29 Page(s): 657 - 660
    09/01/1994 Authors: Kk O; Stoner-Picking J; Yachnin S; Gordon LI; Williams RM; Lis LJ; Westerman MP
  • Effects of fibrinogens on phase transitions in lipid model membrane systems.
    Chem Phys Lipids Volume: 72 Page(s): 1 - 6
    06/24/1994 Authors: Cunningham BA; Kk O; Kwaan HC; Westerman MP; Tracy D; Lis LJ
  • DNA ploidy, proliferative activity, and concanavalin A reactivity in breast cancer.
    J Surg Oncol Volume: 56 Page(s): 21 - 24
    05/01/1994 Authors: Paydas S; Sarpel S; Gilman-Sachs A; Tuncer I; Pehlivan S; Tunali N; Zorludemir S; Burgut R; Kucuk O
  • Increased plasma level of cholesterol-5 beta,6 beta-epoxide in endometrial cancer patients.
    Cancer Epidemiol Biomarkers Prev Volume: 3 Page(s): 571 - 574
    01/01/1994 Authors: Kk O; Churley M; Goodman MT; Franke A; Custer L; Wilkens LR; St Pyrek J
  • Differential sensitivity among 3 human subpopulations in response to 4-nitroquinoline-1-oxide and to bleomycin.
    Int J Oncol Volume: 3 Page(s): 827 - 830
    11/01/1993 Authors: Hsu T; Feun L; Trizna Z; Savaraj N; Shirley L; Furlong C; Schantz S; Weber R; Shen T; Kucuk O
  • Intratumor heterogeneity of DNA ploidy and correlations with clinical stage and histologic grade in prostate cancer.
    J Surg Oncol Volume: 54 Page(s): 171 - 174
    11/01/1993 Authors: Kucuk O; Demirer T; Gilman-Sachs A; Taw I; Mangold M; Singh S; Westerman MP
  • INDUCTION AND PATHOGENESIS OF ANTIPHOSPHOLIPID ANTIBODY (APA) SYNDROME
    JOURNAL OF IMMUNOLOGY Volume: 150 Page(s): A72 - A72
    04/15/1993 Authors: GILMANSACHS A; WONG D; WESTERMAN MP; KUCUK O; BEAMAN KD
  • Antiphospholipid antibodies in sickle cell disease.
    Am J Hematol Volume: 42 Page(s): 380 - 383
    04/01/1993 Authors: Kucuk O; Gilman-Sachs A; Beaman K; Lis LJ; Westerman MP
  • INVITRO STUDIES OF NATURAL-KILLER-CELL ACTIVITY IN POST TRAUMATIC STRESS DISORDER PATIENTS - RESPONSE TO METHIONINE-ENKEPHALIN CHALLENGE
    IMMUNOPHARMACOLOGY Volume: 25 Page(s): 107 - 116
    03/01/1993 Authors: MOSNAIM AD; WOLF ME; MATURANA P; MOSNAIM G; PUENTE J; KUCUK O; GILMANSACHS A
  • In vitro studies of natural killer cell activity in post traumatic stress disorder patients. Response to methionine-enkephalin challenge.
    Immunopharmacology Volume: 25 Page(s): 107 - 116
    01/01/1993 Authors: Mosnaim AD; Wolf ME; Maturana P; Mosnaim G; Puente J; Kucuk O; Gilman-Sachs A
  • RIPPLE PHASE-STABILITY IN LIPID SYSTEMS THAT FORM INTERDIGITATED BILAYERS
    MOLECULAR CRYSTALS AND LIQUID CRYSTALS Volume: 225 Page(s): 33 - 41
    01/01/1993 Authors: CUNNINGHAM BA; WOLFE DH; LIS LJ; QUINN PJ; COLLINS JM; TAMURALIS W; KUCUK O; WESTERMAN MP
  • Variables contributing to anticipatory nausea and vomiting in cancer chemotherapy.
    Am J Clin Oncol Volume: 15 Page(s): 262 - 267
    06/01/1992 Authors: Chin SB; Kucuk O; Peterson R; Ezdinli EZ
  • NON-LAMELLAR PHASES IN SICKLE RED-CELL MEMBRANES
    CLINICAL RESEARCH Volume: 40 Page(s): A425 - A425
    04/01/1992 Authors: WESTERMAN M; KLEPS R; UNGER L; KUCUK O; LIS L
  • Phase transitions between ripple structures in hydrated phosphatidylcholine-cholesterol multilamellar assemblies.
    Phys Rev Lett Volume: 68 Page(s): 1085 - 1088
    02/17/1992 Authors: Wolfe DH; Lis LJ; Kucuk O; Westerman MP; Cunningham BA; Qadri SB; Bras W; Quinn PJ
  • Approaches to and effectiveness of current cancer interventions in the elderly.
    Oncology (Williston Park) Volume: 6 Page(s): 31 - 38
    02/01/1992 Authors: List ND; Kucuk O
  • Inhibition of NK cell-mediated cytotoxicity by oxysterols.
    Cell Immunol Volume: 139 Page(s): 541 - 549
    02/01/1992 Authors: Kucuk O; Stoner-Picking J; Yachnin S; Gordon LI; Williams RM; Lis LJ; Westerman MP
  • The effects of cholesterol oxidation products in sickle and normal red blood cell membranes.
    Biochim Biophys Acta Volume: 1103 Page(s): 296 - 302
    01/31/1992 Authors: Kucuk O; Lis LJ; Dey T; Mata R; Westerman MP; Yachnin S; Szostek R; Tracy D; Kauffman JW; Gage DA
  • PHASE-TRANSITIONS BETWEEN RIPPLE STRUCTURES IN HYDRATED PHOSPHATIDYLCHOLINE-CHOLESTEROL MULTILAMELLAR ARRAYS
    FASEB JOURNAL Volume: 6 Page(s): A501 - A501
    01/01/1992 Authors: CUNNINGHAM BA; WOLFE DH; COLLINS JM; QUINN PJ; LIS LJ; KUCUK O; WESTERMAN MP
  • INFERENCE OF STEROL PSEUDOPLANAR CONFORMATIONS USING LIPID PHASE-RELATIONS
    FASEB JOURNAL Volume: 6 Page(s): A241 - A241
    01/01/1992 Authors: COLLINS JM; NES WD; QUINN PJ; WOLFE DH; CUNNINGHAM BA; KUCUK O; WESTERMAN MP; LIS LJ
  • LOW-TEMPERATURE PHASE-TRANSITIONS IN DIOLEOYLPHOSPHATIDYLCHOLINE BILAYERS - INFLUENCE OF ICE TRANSITIONS
    FASEB JOURNAL Volume: 6 Page(s): A501 - A501
    01/01/1992 Authors: KUCUK O; QUINN PJ; CUNNINGHAM BA; WOLFE DH; WESTERMAN MP; LIS LJ
  • MODULATION OF PHOSPHOLIPID PHASE STRUCTURES AND TRANSITIONS INDUCED BY OXYSTEROLS
    MOLECULAR CRYSTALS AND LIQUID CRYSTALS Volume: 213 Page(s): 213 - 222
    01/01/1992 Authors: LIS LJ; KUCUK O; WESTERMAN MP; TAMURALIS W; QUINN PJ; CUNNINGHAM BA; COLLINS JM; WOLFE DH
  • Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy.
    Med Pediatr Oncol Volume: 20 Page(s): 345 - 348
    01/01/1992 Authors: Chan PD; Berk MA; Kucuk O; Singh S
  • Effect of inserted oxysterols on phospholipid packing in normal and sickle red blood cell membranes.
    Biochem Biophys Res Commun Volume: 180 Page(s): 730 - 734
    10/31/1991 Authors: Szostek R; Kucuk O; Lis LJ; Tracy D; Mata R; Dey T; Kauffman JW; Yachnin S; Westerman MP
  • ANTIPHOSPHOLIPID ANTIBODIES IN SICKLE-CELL DISEASE
    CLINICAL RESEARCH Volume: 39 Page(s): A431 - A431
    04/01/1991 Authors: KUCUK O; GILMANSACHS A; BEAMAN K; LIS L; WESTERMAN MP
  • Diet and stomach cancer incidence. A case-control study in Turkey.
    Cancer Volume: 65 Page(s): 2344 - 2348
    05/15/1990 Authors: Demirer T; Icli F; Uzunalimoglu O; Kucuk O
  • INCREASED CHOLESTEROL OXIDATION-PRODUCTS (OXYSTEROLS) IN SICKLE RED-CELL MEMBRANES
    CLINICAL RESEARCH Volume: 38 Page(s): A539 - A539
    04/01/1990 Authors: KUCUK O; LIS LJ; DEY T; SZOSTEK R; MATA R; CHAMBERLAIN B; GAGE D; SWEELEY C; KAUFFMAN JW; YACHNIN S
  • THE EFFECT OF INSERTED OXIDIZED STEROLS ON SICKLE RED-BLOOD-CELL MEMBRANES
    BIOPHYSICAL JOURNAL Volume: 57 Page(s): A91 - A91
    02/01/1990 Authors: SZOSTEK R; KAUFFMAN JW; KUCUK O; MATA R; DEY T; WESTERMAN MP; LIS LJ
  • EVIDENCE FOR THE PRESENCE OF OXIDIZED STEROL COMPOUNDS IN SICKLE RED-BLOOD-CELL MEMBRANES
    BIOPHYSICAL JOURNAL Volume: 57 Page(s): A91 - A91
    02/01/1990 Authors: KUCUK O; DEY T; MATA R; WESTERMAN MP; LIS LJ; SZOSTEK R; KAUFFMAN JW
  • METHIONINE ENKEPHALIN EFFECT ON CYTO-TOXIC NK ACTIVITY
    ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES Volume: 21 Page(s): R323 - R323
    11/01/1988 Authors: PUENTE J; SEPULVEDA C; GAGGERO A; NAVARRO C; KUCUK O; MOSNAIM AD
  • INHIBITION OF HUMAN NATURAL-KILLER CELL-ACTIVITY BY OXYSTEROLS
    CLINICAL RESEARCH Volume: 36 Page(s): A879 - A879
    10/01/1988 Authors: KUCUK O; STONERPICKING J; YACHNIN S; WESTERMAN MP
  • LABORATORY EVALUATION OF THROMBOCYTOPENIA
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY Volume: 90 Page(s): 508 - 508
    10/01/1988 Authors: RO JO; SCHNEIDER AS; KUCUK O; SARPEL S; HUSSAIN S
  • Lower extremity vasospasm associated with ischemic neuropathy, dermal fibrosis, and digital gangrene in a patient with carcinoid syndrome.
    Cancer Volume: 62 Page(s): 1026 - 1029
    09/01/1988 Authors: Kucuk O; Noskin G; Petersen K; Ezdinli E; Rollins D; Singh S; Sarpel S
  • Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation.
    Exp Hematol Volume: 16 Page(s): 190 - 194
    03/01/1988 Authors: Kies MS; Gordon LI; Rosen ST; Kucuk O; Vriesendorp HM
  • INHIBITION OF MOUSE NATURAL-KILLER (NK) CELL-MEDIATED CYTO-TOXICITY BY OXYGENATED STEROLS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH Volume: 29 Page(s): 373 - 373
    03/01/1988 Authors: KUCUK O; YACHNIN S; PICKING J; GORDON LI; WILLIAMS RM
  • INHIBITION OF MOUSE SPECIFIC CELL-MEDIATED CYTO-TOXICITY BY 2 OXYSTEROLS, 5-ALPHA-HYDROXY-6-KETOCHOLESTANOL AND 6-KETOCHOLESTANOL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH Volume: 29 Page(s): 377 - 377
    03/01/1988 Authors: KUCUK O; YACHNIN S; GORDON LI; WILLIAMS RM; PICKING J
  • Fulminant leukemic polyradiculoneuropathy in a case of B-cell prolymphocytic leukemia. A clinicopathologic report.
    Cancer Volume: 60 Page(s): 1454 - 1458
    10/01/1987 Authors: Haberland C; Cipriani M; Kucuk O; Sarpel G; Ezdinli EZ; Ro JO
  • The effect of intensive intermittent maintenance therapy in advanced low-grade non-Hodgkin's lymphoma.
    Cancer Volume: 60 Page(s): 156 - 160
    07/15/1987 Authors: Ezdinli EZ; Harrington DP; Kucuk O; Silverstein MW; Anderson J; O'Connell MJ
  • INCREASED IMMUNOGLOBULIN CATABOLISM IN CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS WITH HYPOGAMMAGLOBULINEMIA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH Volume: 28 Page(s): 337 - 337
    03/01/1987 Authors: KUCUK O; EZDINLI E; SINCLAIR T; OZKAZANC B; CIPRIANI M; YU E; CHEDID A; GABALA S
  • Effect of the degree of nodularity on the survival of patients with nodular lymphomas.
    J Clin Oncol Volume: 5 Page(s): 413 - 418
    03/01/1987 Authors: Ezdinli EZ; Costello WG; Kucuk O; Berard CW
  • Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation.
    Am J Hematol Volume: 23 Page(s): 223 - 229
    11/01/1986 Authors: Kucuk O; Kwaan HC; Frederickson J; Wade L; Green D
  • The influence of oxygenated sterol compounds on dipalmitoylphosphatidylcholine bilayer structure and packing.
    Chem Phys Lipids Volume: 41 Page(s): 81 - 92
    08/01/1986 Authors: Rooney M; Tamura-Lis W; Lis LJ; Yachnin S; Kucuk O; Kauffman JW
  • Hypogammaglobulinemia and hemophagocytic syndrome associated with lymphoproliferative disorders.
    Cancer Volume: 57 Page(s): 1024 - 1037
    03/01/1986 Authors: Ezdinli EZ; Kucuk O; Chedid A; Sinclair TF; Thomas K; Singh S; Sarpel S; Jovanovic L
  • Oxygenated cholesterols synergistically immobilize acyl chains and enhance protein helical structure in human erythrocyte membranes.
    Biochim Biophys Acta Volume: 820 Page(s): 33 - 39
    10/24/1985 Authors: Rooney MW; Yachnin S; Kucuk O; Lis LJ; Kauffman JW
  • Amsacrine and etoposide induced paralytic ileus in a patient with acute myelomonocytic leukemia.
    J Surg Oncol Volume: 28 Page(s): 172 - 173
    03/01/1985 Authors: Kucuk O; Apostol JV
  • Thromboembolic complications associated with L-asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma.
    Cancer Volume: 55 Page(s): 702 - 706
    02/15/1985 Authors: Kucuk O; Kwaan HC; Gunnar W; Vazquez RM
  • SYNERGISTIC EFFECT OF 20-HYDROXYCHOLESTEROL ON THE ACYL CHAIN IMMOBILIZING BEHAVIOR OF CHOLESTEROL IN HUMAN-ERYTHROCYTE MEMBRANES
    BIOPHYSICAL JOURNAL Volume: 47 Page(s): A159 - A159
    01/01/1985 Authors: ROONEY MW; KAUFFMAN JW; YACHNIN S; KUCUK O; LIS LJ
  • RED BLOOD-CELL HYPERAGGREGABILITY DUE TO INCREASED PROTEIN ALPHA-HELICAL ORDER OF FIBRINOGEN IN PATIENTS WITH DISTAL EXTREMITY GANGRENE
    THROMBOSIS AND HAEMOSTASIS Volume: 54 Page(s): 23 - 23
    01/01/1985 Authors: KWAAN HC; ROONEY MW; KAUFFMAN TW; KUCUK O
  • THE INFLUENCE OF OXIDIZED STEROL COMPOUNDS ON DIPALMITOYLPHOSPHATIDYLCHOLINE STRUCTURE AND PACKING
    BIOPHYSICAL JOURNAL Volume: 47 Page(s): A427 - A427
    01/01/1985 Authors: ROONEY M; KAUFFMAN JW; TAMURALIS W; LIS LJ; YACHNIN S; KUCUK O
  • Separation of clonogenic tumor cells from small cell lung cancer bone marrow and small cell lung cancer cell lines.
    Cancer Res Volume: 44 Page(s): 5404 - 5408
    11/01/1984 Authors: Gordon LI; Rosen ST; Vriesendorp HM; Kies MS; Kucuk O
  • Estimation of hemopoietic potential by CFU-c and bone marrow scan in cancer patients.
    Exp Hematol Volume: 12 Page(s): 101 - 106
    02/01/1984 Authors: Kucuk O; Gordon LI; Kies MS; Spies S; Spies W; Vriesendorp HM
  • 5-AZACYTIDINE (AZA) + AMSA FOR REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA
    CLINICAL RESEARCH Volume: 32 Page(s): A753 - A753
    01/01/1984 Authors: LARSON RA; WINTER JN; KUCUK O; KWANN H
  • H-2 gene control of resistance to P815-X2 mastocytoma.
    Cancer Res Volume: 43 Page(s): 5754 - 5757
    12/01/1983 Authors: Kwak LW; Kucuk O; Melvold RW; Williams RM
  • Estrogen receptor analysis in chronic lymphocytic leukemia.
    Blood Volume: 62 Page(s): 996 - 999
    11/01/1983 Authors: Rosen ST; Maciorowski Z; Wittlin F; Epstein AL; Gordon LI; Kies MS; Kucuk O; Kwaan HC; Vriesendorp H; Winter JN
  • H-2-linked resistance to mastocytoma in male mice: immune response to a histocompatibility antigen on the X chromosome.
    Science Volume: 220 Page(s): 959 - 961
    05/27/1983 Authors: Kwak LW; Kucuk O; Melvold RW; Williams RM
  • ESTIMATION OF HEMATOPOIETIC POTENTIAL BY CFU-C AND BONE-MARROW SCAN IN CANCER-PATIENTS
    EXPERIMENTAL HEMATOLOGY Volume: 10 Page(s): 52 - 52
    01/01/1982 Authors: KUCUK O; GORDON LI; KIES MS; SPIES S; SPIES W; VRIESENDORP HM
  • Angioimmunoblastic lymphadenopathy with cholestasis and intravascular coagulation.
    Clin Oncol Volume: 8 Page(s): 273 - 278
    01/01/1982 Authors: Kucuk O; Gynn TN
  • Myocardial infarction and factor VIII.
    J Chronic Dis Volume: 35 Page(s): 231
    01/01/1982 Authors: Green D; Kucuk O; Haring O; Dyer A
  • INHIBITION OF CELL-MEDIATED CYTO-TOXICITY AND NATURAL-KILLER CELL-ACTIVITY BY OXYGENATED STEROL COMPOUNDS
    FEDERATION PROCEEDINGS Volume: 40 Page(s): 1127 - 1127
    01/01/1981 Authors: KUCUK O; GORDON LI; YACHNIN S; WILLIAMS RM
  • MUTATIONS AT THE H-2KB, H-2DB, AND I-AB GENES INFLUENCE HYBRID RESISTANCE TO P815
    FEDERATION PROCEEDINGS Volume: 40 Page(s): 1160 - 1160
    01/01/1981 Authors: KWAK LW; KUCUK O; MELVOLD RW; WILLIAMS RM
  • The factor VIII complex in atherosclerosis: effects of aspirin.
    J Chronic Dis Volume: 34 Page(s): 21 - 26
    01/01/1981 Authors: Green D; Kucuk O; Haring O; Dyer A
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements